Effect of Organic Solvents on the Structural Stability of Human Serum Albumin by Kumar, Yogesh
rifESl5 
EFFECT OF ORGANIC SOLVENTS ON 
THE STRUCTURAL STABILITY OF 
HUMAN SERUM ALBUMIN 
', %%u 
7 '^ ' ~ . 
ir.^ol3 YOGESH KUMAR 
A thesis submitted in fulfilment of the requirements for the 
degree of Doctor of Philosophy in Biotechnology of the 
Aligarh Muslim University 
ALIGARH 
2001 
ABSTRACT 
Human serum albumin (HSA) is the most abundant protein circulating in blood 
and it transports a wide variety of ligands. Sequence and X-ray structural analysis 
of HSA indicate that the protein features several double loops stabilized by 
disulfide bonds and that it can be grouped into three homologous domains, I, II, 
and III. Studies on chemically and enzymatically isolated domains have shown 
that they have structural features as well as ligand binding properties correlating 
to their specific functionality in the context of the native protein. The 
denaturation of serum albumin is reversible as shown by exposing it to extremes 
of variety of conditions, including pH, temperature, pressure and chemical 
denaturants like urea, GdnHCl and cationic detergents. On lowering the pH, the 
protein undergoes isomerization forming an 'F' form at around pH 4.0 and an 'E' 
form at around pH 2.5. The urea-induced denaturation of serum albumin is a two-
step process occurring through an intermediate state, on the other hand, the 
GdnHCl-induced denaturation is found to be a single-step process. This suggests 
the involvement of electrostatic interactions in the formation of intermediate 
state. The molten globule state, a general intermediate in the folding pathway of 
proteins formed under mild denaturing conditions, has not been characterized 
hitherto in serum albumin at low pH (~2.0). Further, alcohol-induced partially 
folded states of HSA have not been studied in detail. These issues prompted me 
to characterize the acid-denatured state of HSA at low pH (~2.0) and to examine 
i i 
the effect of alcohols on this state. Effect of alcohols on urea-induced 
denaturation of HSA was also studied. 
In order to characterize the acid-denatured 'E' form of human serum 
albumin, we used far- and near-UV circular dichroism (CD), binding of a 
hydrophobic probe, l-anilino-8-napthalene sulphonic acid (ANS), thermal 
transition by far- and near-UV CD, tryptophan fluorescence, quenching of 
tryptophan fluorescence using a neutral quencher, acrylamide and viscosity 
measurements. The results showed that HSA at pH 2.0 was characterized by a 
significant amount of secondary structure as evident from far-UV CD spectra. 
The near-UV CD spectra showed a profound loss of tertiary structure. A marked 
increase in ANS fluorescence signified a large solvent exposure of non-polar 
clusters. The temperature dependence of both near-and far-UV CD signals did 
not exhibit a cooperative thermal transition. The intrinsic fluorescence and 
acrylamide quenching of the lone tryptophan residue, Trp2i4 showed that in the 
acid denatured state, the lone tryptophan residue is buried in the interior in a non-
polar environment. The intrinsic viscosity measurements showed that the acid-
denatured state is relatively compact compared to that of the denatured state in 
7.0 M guanidine hydrochloride. Taken together, these results, i.e. the presence of 
a high content of secondary structure (-42% a-helix), higher magnitude of ANS 
binding, loss of cooperativity in the thermal transition and significant loss of 
tertiary structure but retention of compactness, suggest that the acid-denatured 
state of HSA at pH 2.0 resembles the molten globule state as defined for other 
i i i 
proteins. In view of previous results showing uncoiling of domain III on 
acidification, loss of secondary structure may be attributed to unfolding of 
domain III, whereas retention of other properties similar to those of the native 
state can be ascribed to domains I and II. 
Human serum albumin (HSA) at pH 2.0 represents the molten globule 
state. In view of the helix stabilizing potential of alcohols, we studied the effect 
of various alkanols and halogenated alcohols, viz. methanol, ethanol, 
isopropanol, tert-butanol, 2-chloroethanol, trifluoroethanol (TFE) and 
hexafluoroisopropanol (HFIP) on the acid-denatured state of HSA by far-UV 
circular dichroism (CD), near-UV CD, tryptophan fluorescence and 
l-anilino-8-naphthalene sulfonic acid (ANS) binding. Upon addition of different 
alcohols, HSA exhibited a transition from the acid-denatured state to the 
a-helical state as evident from the increase in mean residue ellipticity (MRE) 
value at 222 nm and loss of ANS binding sites reflected by the decrease in ANS 
fluorescence at 480 nm. However, the concentration range required to bring 
about the transition varied greatly among different alcohols. HFIP was found to 
have high potential whereas methanol was least effective in inducing the 
transition. The order of effectiveness of alcohols was shown to be: HFIP > TFE > 
2-chloroethanol > tert-butanol > isopropanol > ethanol > methanol as evident 
from the Cm values. The near-UV CD spectra and tryptophan fluorescence 
showed the differential effects of halogenated alcohols with those of alkanols. A 
comparison of the m values, showing the dependence of AGH on alcohol 
concentration suggests that the helix stabiHzing potential of different alcohols is 
due to the additive effect of different constituent groups present whereas 
remarkably higher potential of HFIP involves some other factor in addition to the 
contribution of constituent groups. 
Urea-induced equilibrium unfolding of HSA when studied by MRE222 or 
intrinsic fluorescence measurements showed a two-step, three-state transition 
with a stable intermediate around 4.6-5.2 M urea. Presence of TFE in the 
incubation mixture resulted in a single-step, two-state transition with a significant 
shift towards higher urea concentration suggesting the stabilizing effect of TFE. 
The free energy of stabilization (AAGD ^ ) in the presence of 3M TFE was found 
to be 2,680 and 2,720 cal/mol when determined by MRE222 and fluorescence 
measurements, respectively. Similar stabilizing effect of TFE on urea 
denaturation of HSA was noticed when studied by ANS binding in which mid 
point of transition was found to be 6.7 M urea in the presence of 3M TFE against 
5.5 M urea in its absence. The stabilizing potential of other alcohols on the 
refolding behavior of HSA at 5.0 M urea (where intermediate exists) as studied 
by MRE222 and intrinsic fluorescence measurements showed the following order: 
HFIP > TFE >2-chloroethanol > tert-butanol >isopropanol > ethanol > methanol. 
Further, extent of refolding at the highest concentration of alcohol was 
found to be similar in all cases. Stabilizing effect of TFE on GdnHCl-induced 
unfolding of HSA was nearly equal to that studied with urea denaturation as 
H O 
reflected from AAGD ^ value (2,385 cal/mol). Taken together, these results 
suggest the stabilizing effect of TFE and other alcohols on urea/GdnHCl-induced 
unfolding of HSA, being higher with alcohols with bulky groups or containing 
fluorine atoms. 
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ABSTRACT 
Human serum albumin (HSA) is the most abundant protein circulating in blood 
and it transports a wide variety of ligands. Sequence and X-ray structural analysis 
of HSA indicate that the protein features several double loops stabilized by 
disulfide bonds and that it can be grouped into three homologous domains, I, II, 
and III. Studies on chemically and enzymatically isolated domains have shown 
that they have structural features as well as ligand binding properties correlating 
to their specific functionality in the context of the native protein. The 
denaturation of serum albumin is reversible as shown by exposing it to extremes 
of variety of conditions, including pH, temperature, pressure and chemical 
denaturants like urea, GdnHCl and cationic detergents. On lowering the pH, the 
protein undergoes isomerization forming an 'F' form at around pH 4.0 and an 'E' 
form at around pH 2.5. The urea-induced denaturation of serum albumin is a two-
step process occurring through an intermediate state, on the other hand, the 
GdnHCl-induced denaturation is found to be a single-step process. This suggests 
the involvement of electrostatic interactions in the formation of intermediate 
state. The molten globule state, a general intermediate in the folding pathway of 
proteins formed under mild denaturing conditions, has not been characterized 
hitherto in serum albumin at low pH (~2.0). Further, alcohol-induced partially 
folded states of HSA have not been studied in detail. These issues prompted me 
to characterize the acid-denatured state of HSA at low pH (~2.0) and to examine 
the effect of alcohols on this state. Effect of alcohols on urea-induced 
denaturation of HSA was also studied. 
In order to characterize the acid-denatured 'E' form of human serum 
albumin, we used far- and near-UV circular dichroism (CD), binding of a 
hydrophobic probe, l-anilino-8-napthalene sulphonic acid (ANS), thermal 
transition by far- and near-UV CD, tryptophan fluorescence, quenching of 
tryptophan fluorescence using a neutral quencher, acrylamide and viscosity 
measurements. The results showed that HSA at pH 2.0 was characterized by a 
significant amount of secondary structure as evident fi-om far-UV CD spectra. 
The near-UV CD spectra showed a profound loss of tertiary structure. A marked 
increase in ANS fluorescence signified a large solvent exposure of non-polar 
clusters. The temperature dependence of both near-and far-UV CD signals did 
not exhibit a cooperative thermal transition. The intrinsic fluorescence and 
acrylamide quenching of the lone tryptophan residue, Trp2i4 showed that in the 
acid denatured state, the lone tryptophan residue is buried in the interior in a non-
polar environment. The intrinsic viscosity measurements showed that the acid-
denatured state is relatively compact compared to that of the denatured state in 
7.0 M guanidine hydrochloride. Taken together, these results, i.e. the presence of 
a high content of secondary structure (~42% a-helix), higher magnitude of ANS 
binding, loss of cooperativity in the thermal transition and significant loss of 
tertiary structure but retention of compactness, suggest that the acid-denatured 
state of HSA at pH 2.0 resembles the molten globule state as defined for other 
in 
proteins. In view of previous results showing uncoiling of domain III on 
acidification, loss of secondary structure may be attributed to unfolding of 
domain III, whereas retention of other properties similar to those of the native 
state can be ascribed to domains I and II. 
Human serum albumin (HSA) at pH 2.0 represents the molten globule 
state. In view of the helix stabilizing potential of alcohols, we studied the effect 
of various alkanols and halogenated alcohols, viz. methanol, ethanol, 
isopropanol, tert-butanol, 2-chloroethanol, trifluoroethanol (TFE) and 
hexafluoroisopropanol (HFIP) on the acid-denatured state of HSA by far-UV 
circular dichroism (CD), near-UV CD, tryptophan fluorescence and 
l-anilino-8-naphthalene sulfonic acid (ANS) binding. Upon addition of different 
alcohols, HSA exhibited a transition from the acid-denatured state to the 
a-helical state as evident from the increase in mean residue ellipticity (MRE) 
value at 222 nm and loss of ANS binding sites reflected by the decrease in ANS 
fluorescence at 480 nm. However, the concentration range required to bring 
about the transition varied greatly among different alcohols. HFIP was found to 
have high potential whereas methanol was least effective in inducing the 
transition. The order of effectiveness of alcohols was shown to be: HFIP > TFE > 
2-chloroethanol > tert-butanol > isopropanol > ethanol > methanol as evident 
fi-om the Cm values. The near-UV CD spectra and tryptophan fluorescence 
showed the differential effects of halogenated alcohols with those of alkanols. A 
comparison of the m values, showing the dependence of AGH on alcohol 
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concentration suggests that the heUx stabilizing potential of different alcohols is 
due to the additive effect of different constituent groups present whereas 
remarkably higher potential of HFIP involves some other factor in addition to the 
contribution of constituent groups. 
Urea-induced equilibrium unfolding of HSA when studied by MRE222 or 
intrinsic fluorescence measurements showed a two-step, three-state transition 
with a stable intermediate around 4.6-5.2 M urea. Presence of TFE in the 
incubation mixture resulted in a single-step, two-state transition with a significant 
shift towards higher urea concentration suggesting the stabilizing effect of TFE. 
H O 
The free energy of stabilization (AAGD 2 ) in the presence of 3M TFE was found 
to be 2,680 and 2,720 cal/mol when determined by MRE222 and fluorescence 
measurements, respectively. Similar stabilizing effect of TFE on urea 
denaturation of HSA was noticed when studied by ANS binding in which mid 
point of transition was found to be 6.7 M urea in the presence of 3M TFE against 
5.5 M urea in its absence. The stabilizing potential of other alcohols on the 
refolding behavior of HSA at 5.0 M urea (where intermediate exists) as studied 
by MRE222 and intrinsic fluorescence measurements showed the following order: 
HFIP > TFE >2-chloroethanol > tert-butanol >isopropanol > ethanol > methanol. 
Further, extent of refolding at the highest concentration of alcohol was 
found to be similar in all cases. Stabilizing effect of TFE on GdnHCl-induced 
unfolding of HSA was nearly equal to that studied with urea denaturation as 
H O 
reflected from AAGD ^ value (2,385 cal/mol). Taken together, these results 
suggest the stabilizing effect of TFE and other alcohols on urea/GdnHCl-induced 
unfolding of HSA, being higher with alcohols with bulky groups or containing 
fluorine atoms. 
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INTRODUCTION 
Serum albumin is the most abundant and multifunctional protein in the 
circulatory system. It is classified to a multigene family of proteins that includes 
a-fetoprotein (AFP) and human group-specific component (Gc) or Vitamin 
D-binding protein. Serum albumin, also known as plasma albumin, was 
recognized as a principal component of blood as early as 1839 (Ancell, 1839). It 
was crystallized nearly a century ago directly from horse plasma (Gurber, 1895). 
It constitutes about 60% of the total serum proteins, serving the transport, 
distribution and metabolism of many exogenous and endogenous ligands (Peters, 
1985). There is a plethora of reviews including from comprehensive (Foster, 
1960; Peters, 1970; 1980; 1984; 1985; 1992; Brown & Shockley, 1982; Carter & 
Ho, 1994; Kragh-Hansen, 1981; 1990) to those, which deal with metabolism 
(Rothschilds et al., 1980; 1988; Tayek, 1988), clinical uses (Alexander et al., 
1982; Erstad et al., 1991) and production (Finlayson, 1980; Vezon, 1989). A 
book on serum albumin has also been published (Peters, 1996). 
Biosynthesis 
The synthesis of albumin in mammals takes place in the liver (Peters & 
Anfinsen, 1950). Albumin mRNA contains about 2080 base pairs of which 
39 precede the F-Met initiation codon and 210 follow the translation termination 
codon including a 24 base pairs long poly (A) stretch. The synthesis starts with 
the attachment of 19 ribosomes to one mRNA molecule to form a large 
2 
polysome. It is synthesized as 'preproalbumin' containing a leader 
sequence/signal peptide, a stretch of 18 amino acid residues, is the first translated 
sequence which directs the growing peptide chain through the membrane of 
endoplasmic reticulum before being cleaved off even before the completion of 
the RNA translation. Folding and formation of its 17-disulfide bonds take place 
immediately after the emergence of peptide chain into the lumen of endoplasmic 
reticulum and are complete within 0.5 minutes of completion of the chain (Peters 
& Davidson, 1982). The newly formed albumin called 'proalbumin' contains a 
stretch of a basic hexapeptide (Arg-Gly-Val-Phe-Arg-Arg) attached to its amino 
terminal end (Urban et al, 1974). This leader peptide guides the polypeptide 
chain from endoplasmic reticulum to Golgi complex for proteolytic processing 
and secretion (Judah, 1983). The leader hexapeptide is cleaved in the Golgi 
complex (secretory vesicles) before the release of albumin from the cell in its 
biologically active form. The entire process for albumin requires 20-30 minutes. 
Genetics 
The complementary DNA molecules (cDNAs) for albumin mRNAs of 
several species have been cloned in E. coli and their nucleotide base sequences 
determined. Using DNA as hybridization tool, genes for serum albumin of 
human (Hawkins & Dugaiczyk, 1982), rat (Sargent et al, 1983), mouse (Kioussis 
et al, 1981) and a number of other organisms have been isolated. The human 
albumin gene contains nearly 17000 nucleotides (Minghetti et al, 1986), which 
split into 15 exons by 14 intervening sequences (introns). In man, there is a single 
copy of the albumin gene, situated on the short arm of chromosome 4, at 4ql 1-22 
(Kumit et al, 1982). It lies 14.5 Kbases 5' to (upstream of) (Urano et al, 1984) 
the gene for a-fetoprotein (Minghetti et al, 1983) and adjacent to the gene for 
vitamin D-binding protein (Gc globulin) (Cooke et al, 1986). 
The 15 exons created by these 14 introns are designated by the letters 
'ZABCDEFGHIJKLMN'. The leader exon, Z, contains the 5'-untranslated portion 
of albumin mRNA, including the initiation and capping sites and encodes the 
18-residue signal peptide, the 6-residue propeptide and the first 2"^  residues of 
the albumin chain (Peters, 1985). The length of the introns does not repeat, but 
the sites of their insertions correspond to regular loci in the albumin chain, i.e., in 
the ascending limb of all six of the long loops, 1, 3, 4, 6, 7, 9 and linking chain 
segment after each of these loops. The intron in loop 4 occurs precisely at the 
conservative tryptophan residue, Trp-214. Domains I, II and III are encoded by 
exons 'ABCD', 'EFGH' and 'IJKL', respectively. C-terminal end (571-584) and 
the termination codon are encoded by exon 'M'. Polyadenylation site and 
3' terminus of the gene resides in exon N. The TATA box lies in the 5' region at 
position -32, downstream from the CAT box at position -88. Another 'TATA 
box' lies at position 793 (Minghetti et al, 1986; Urano et al, 1986). 
Distribution and turnover 
Serum albumin is the major protein component of blood plasma; occurring 
there at a concentration of around 40 mg/ml (-0.6 mM) (Peters, 1996) and in the 
interstitial fluids it varies between 0.2 and 0.5 mM (Spector, 1986). About 40% 
of the total albumin is found in the circulatory plasma (Peters, 1992) whereas 
remaining 60% resides about half in viscera and half in muscle and skin 
(Rabilloud et ah, 1988). It has been found in all body fluids, in milk (Phillippy & 
McCarthy, 1979), amniotic fluid (Bala et al, 1987), semen (Blumsohn et ai, 
1991) and mammary cysts (Balbin et al., 1991). The concentration of albumin 
declines slightly with age (Cooper & Gardner, 1989) and is lower in newborns 
(Cartlidge & Rutter, 1986) and as low as 20 g/L in premature infants (Reading et 
ai, 1990). The normal rate of albumin production is 0.7 mg'g liver per hour 
(Peters, 1985). The rate of albumin synthesis depends both on the supply of 
amino acids (Kaysen et ai, 1989) as well as the rate of protein catabolism 
(Morgan & Peters, 1971; 1972). About 4-5% of albumin is replaced by hepatic 
synthesis daily (Olufemi et al., 1990). The degradation of albumin in human 
follows first order kinetics with an average half-life of 19 days (Waldmann, 
1990). The anabolic hormones, insulin and somatotropin maintained albumin 
concentration in plasma through transcriptional control of the albumin gene 
{Uutson etal., 1987). 
Physico-chemical properties 
Physico-chemical properties of human serum albumin are summarized in 
Table 1. The molecular weight of albumins is less than that of most of the other 
plasma proteins. The value obtained from the physical data i.e. 69,000 
(Charlwood, 1961) for human serum albumin was found to be little higher than 
the value 66,438 calculated from the complete amino acid sequence (Dugaiczyk 
Table 1 
Physico-chemical properties of human serum albumin 
Property 
Molecular weighf 
Number of residues 
a-helix, (%) 
P-tums, (%) 
1% 
E lanat 280 nm 
Partial specific volume (cm /g) 
Sedimentation coefficient, S°2o,w (S) 
Diffusion coefficient, D°2o,w (dcm /^s) 
Intrinsic viscosity, [r|] 
Radius of gyration^ 
Molecular dimensions'* 
Equilateral triangle 
side (A) 
depth (A) 
Molecular volume'' (A)^  
Molecular surface area (A)^  
Isoelectric point 
defatted 
fatted (1-2 fatty acids) 
Value 
66,439 
585 
-65 
-10 
5.30 
0.733 
4.5x10-'^  
6.1x10-^  
0.042 
26.7 
80 
30 
88248.9 
8202.1 
-5.3 
-4.7 
Reference 
Peters (1985) 
Peters (1985) 
Pearson (1990) 
Carter & Ho (1994) 
Pace era/. (1995) 
Charlwood(1961) 
Oncley era/. (1947) 
Oncley et al. (1947) 
Charlwood(1961) 
Carter & Ho (1994) 
He & Carter (1992) 
He & Carter (1992) 
Carter & Ho (1994) 
Carter & Ho (1994) 
Carter & Ho (1994) 
Carter & Ho (1994) 
^Calculated from the amino acid composition. 
''Calculated from the atomic coordinates of HSA (He & Carter, 1992 ). 
et al., 1982). This value was corrected to 66,605±7 as determined from 
electrospray ionization mass spectrum of HSA (Loo et al., 1991). The X-ray 
crystallographic studies (He & Carter, 1992) revealed the structure of HSA to be 
a heart shaped molecule that can be approximated to an equilateral triangle with 
sides of-80 A and a depth of-30 A. Therefore, under neutral conditions of pH, 
it has an axial ratio of approximately 2.66 which is in agreement with the value 
of 3.0 based on studies of dielectric and birefringence relation times (Moser et 
al., 1966). The solvent-accessible surface and molecular volume of HSA are 
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28,202 A and 88,249 A respectively, calculated using the molecular 
coordinates and the algorithm of Richards (1985). The radius of gyration of HSA 
is 26.7 A, similar to the value (26.4 A) of hydrodynamic radius of HSA 
(rotational) measured by light scattering and electron spin resonance (ESR) 
(Cannistraro & Sacchetti, 1986). The albumin structure is predominantly 
a-helical. Approximately, 67% of HSA is helical with the remaining 
polypeptides occuring in turns (-10%) and extended or flexible regions between 
subdomains (-23%)) (Carter & Ho, 1994). Hydrodynamically, HSA shows a 
sedimentation coefficient, S''20,wOf 4.5 x 10"'^  S, diffusion coefficient, 0%^ of 
6.0 X 10'^  cmVsec (Oncley et al., 1947) and partial specific volume of 0.733 cc/g 
(Charlwood, 1961). The intrinsic viscosity has been measured as 4.2 and 4.1 cc/g 
for HSA and BSA, respectively (Charlwood, 1961). Defatted albumin has an 
isoelectric point of-5.3 against -4.7 for fatted HSA. At physiological pH, the 
calculated net charge is -15 (Peters, 1985). High charge on the protein molecule 
is responsible for its high solubihty in water and a solution as concentrated as 
30% (w/v) can be prepared (Peters, 1985). Spectral properties of HSA have been 
extensively reviewed (Peters, 1992). The specific absorption coefficient, E °icm 
at 279 nm is 5.31 for HSA (Edwards et al, 1969). The lower value of specific 
extinction coefficient (6.61 for BSA and 5.3 for HSA) as well as maximum 
absorption at 279 nm is mainly because of the low content of tryptophan in 
bovine and human serum albumins (Peters, 1985). 
Amino acid composition 
Table 2 shows the amino acid composition of human serum albumin. HSA 
contains 585 amino acid residues in a single polypeptide chain (Lawn et al, 
1981; Dugaiczyk et al., 1982). Albumin is non-glycoprotein, one of the few 
secreted proteins, which lacks carbohydrate or any other non-protein moiety. It is 
characterized by a low content of methionine and glycine and contains only a 
single tryptophan (Peters, 1985). It has high content of cystine and charged 
amino acids, aspartic and glutamic acids, lysine and arginine (see Table 2) 
(Brown & Shockley, 1982). The acidic amino acids outnumber the basic ones 
giving acidic character to albumin molecule. The distribution of amino acids is 
uneven. Glycine is concentrated in the amino half of the molecule where as 
threonine favors the carboxyl half of the molecule. Asparagine and glutamine 
occurs in greater frequency near the ends than in the middle. Tyrosines are 
heavily concentrated in loop 3 and loop 6 and prolines occur at the tip of each 
loop. It contains 17 disulfide bridges and one free thiol group (Cys-34). 
Table 2 
Amino acid composition of human serum albumin^ 
Amino acid Residues 
Alanine 
Valine 
Leucine 
Isoleucine 
Proline 
Phenylalanine 
Tryptophan 
Methionine 
Cysteine 
Glycine 
Threonine 
Serine 
Tyrosine 
Aspartic acid 
Asparagine 
Glutamic acid 
Glutamine 
Lysine 
Arginine 
Histidine 
Total 
Number of nitrogen atoms 
Calculated net charge, pH 7.0 
Average residue weight 
62 
41 
61 
8 
24 
31 
1 
6 
35 
12 
28 
24 
18 
36 
17 
62 
20 
59 
24 
16 
585 
786 
-15 
113.57 
'Taken from Peters (1996). 
Primary structure 
Amino acid sequence and disulfide bonding patterns 
Figure 1 shows complete sequence of human serum albumin (Behrens et 
al, 1975; He & Carter, 1992) (Figure 1). The most unique structural feature of 
the albumin is its disulfide bonding patterns. The 17 disulfide bridges of HSA are 
characterized by a unique arrangement of disulfide double loops that repeat as a 
series of triplets. They are positioned in a repeating series of nine loop-link-loop 
structures centered on eight sequential Cys-Cys pairs (Figure 2). The 
conformations of the disulfides are primarily gauche-gauche-gauche 
(CP1-S1-S2-CP2) with torsion angles clustering around ±80° (He & Carter, 1992). 
The repetition of these loops in a triplet fashion of large-small-large can group 
these loops into three homologous domains (I, II and III) comprising of residues 
1-190, 191-382 and 383-585 in the primary sequence of HSA (Brown, 1977). 
None of the disulfides are accessible to the solvent but they become accessible 
with the unfolding of the albumin (Katchalski et al., 1957). The lone sulfhydryl 
Cys 34 has a low pKsH of 5 as compared to 8.5 and 8.9 of cysteine and 
glutathione (Pederson & Jacobson, 1980). Cys 34, the only cysteine with a 
sulfhydryl group does not participate in a disulfide linkage with any external 
ligands. The crystal structure of HSA indicates that Cys 34 is located in a crevice 
with Glu 82 and His 39 lying in the close proximity (Carter & Ho, 1994). The 
sequence homology between these domains is 18-25% (Brown, 1977). The 
charge distribution of HSA at neutral pH for domains I, II and III are -9, -8 and 
+2 respectively (Peters, 1985). From the observations of these loops and other 
Figure 1. Amino acid sequence of human serum albumin. The 
arrangement showing the heart-shaped structure, is based on a design 
by D.C. Carter. Approximate helical regions are boxed and number at 
their starting points, numbered 1-10 for each domain. Ligand sites in 
subdomains n and III are indicated by asterisks (Taken from He and 
Carter, 1992). 
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Figure 2. Schematic representation of secondary structure elements 
and disulfide bridges of HSA. Helices are represented by rectangles, 
and loops and turns by thin lines (Taken fi-om Sugio et al, 1999). 
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homologies, Brown (1977) and McLachlan & Walker (1977) deduced that 
albumin has evolved from smaller proteins, one third or even one ninth of the 
present size by gene fusion. High percentages of sequence homologies have been 
found among different albumins being 76% between HSA and BSA (Peters, 
1985); 76% between horse serum albumin (ESA) and HSA; 73% between ESA 
and BSA; 76% between (ESA) and rat serum albumin (RSA) (Ho et al, 1983); 
61% among 1992). About 50% conserved residues are found in all known 
albumin sequences (Carter & Ho, 1994). 
Three dimensional structure 
X-ray structure 
The three dimensional structure of HSA was first determined 
crystallographically to a resolution of 2.8 A by He & Carter (1992). Recently, the 
crystal structure of HSA has been determined at a resolution of 2.5 A by Sugio et 
al. (1999)(Figure 3). HSA is a helical protein with turns and loops, and resembles 
a heart shape, with approximate dimensions of 80x80x30 A. It consists of three 
domains, I (1-190), II (191-382), III (383-585), which are not topologically 
identical, as predicted from amino acid sequence comparison, but are also very 
similar in three dimensional structure. Each domain can be further divided into 
subdomains A and B, which are composed of six and four a-helices, 
respectively. Subdomain A is composed in each case a cluster of four a-helices 
(a-hl to h4) flanked by two short a-helices (a-h5 and a-h6). Whereas subdomain 
B in each case has another cluster of four helices (b-hl to h4). Helices h2-h4 in 
Figure 3. Crystal Structure of human serum albumin at 2.5 A 
resolution. Each domain is marked with a different colour (yellow 
for subdomain la; green, lb; red, Ila; magenta, lib; blue, Ilia; and cyan, 
Illb). N- and C- termini are marked as N and C, respectively (Taken 
from Sugio et al., 1999). 
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subdomain A are structurally homologous to helices h8-hlO from subdomain B. 
The subdomains are joined by stretch of extended polypeptides (lA-IB, 106-119; 
IIA-IIB, 292-315; IIIA-IIIB, 492-511). An extended loop traverses the two 
subdomains to link them together. The helix clusters found in subdomains A and 
B are also similar in three dimensional structure and are approximately related by 
a two fold axis situated between helices A-h2 and B-h2. The last helices (B-h4) 
of domain I and domain II are fused with the first helices (A-hl) of the next 
domains giving the total number of helices in a HSA molecule as 28 rather than 
30 (He & Carter, 1992). Domains I and II are almost perpendicular to each other 
to form a T-shaped assembly in which the tail of subdomain IIA is attached to the 
interface region between subdomain lA and IB by hydrophobic interactions and 
hydrogen bonds. In contrast, domain III protrudes from subdomain IIB at an 
angle of about 45 A to form a Y-shaped assembly for domain. Domain III 
interacts only with subdomain IIB. These features make the HSA molecule a 
heart shaped. There are few contacts between domains I and III due to a large 
channel formed by subdomain IB, IIA and IIB. On superimposing a-carbons of 
the individual domains of HSA, an average root mean square (RMS) difference 
between a-carbons of 3.77, 4.32 and 3.63 A was obtained for domains I-II, I-III 
and II-III respectively (He & Carter, 1992). Further, the six subdomains share a 
common helical motif which corresponds to the amino acids encompassed within 
the double disulfide loops 1, 3, 4, 6, 7 and 9 wherein each motif is related by a 
pseudo twofold axis (1:168°, 11:163° and 111:171°) (Carter & Ho, 1994). The RMS 
distances between the corresponding a-carbons of the common motifs of 
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subdomains A and B are 2.47 A, 2.53 A and 2.60 A for domains I, II and III 
respectively. Distinct differences between subdomains A and B also exist. The A 
subdomains supplement the three-helix bundle on the C-terminal side with an 
additional but smaller disulfide double loop (loops 2, 5, and 8) to form a small 
globin-like fold that is extensively cross-linked by four disulfide bridges. The B 
subdomains supplement the helical motif on the N-terminal side with a 
conformationally extended polypeptide to create a folding topology that closely 
resembles a simple up-down helical bundle. Subdomains A and B assemble 
through hydrophobic helix packing interactions primarily involving h2, h3 and 
h8. Additionally, the subdomains are linked together by a presumed 
flexible extension of polypeptide encompassing residues Lysl06—Glull9, 
Glu292—Val315 and Glu492—Ala511 in the domains I, II and III respectively. 
Domains I-II and II-III in turn are connected through extensions of hlO(I)-hl(II) 
and hlO(II)-hl(III) respectively creating the two longest helices in HSA. 
Domains II and III both have a pocket formed mostly of hydrophobic and 
positively charged residues and in which a wide range of compounds may be 
accommodated. 
Heterogeneity 
Heterogeneity is often exhibited by albumin molecules, which may arise 
because of ligand binding, protein-protein association (Giuliani et al, 1981; 
Moehring et al, 1983) and/or modification of its amino acid side chains (Meucci 
et al, 1991). Albumin preparations show two types of heterogeneity, which can 
be classified as macroheterogeneity and microheterogeneity. Macroheterogeneity 
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has been attributed to the formation of dimers, oHgomers or polymers of albumin 
(Finlyson et ai, 1960; Friedli & Kistler, 1970; Barnes et al, 1974). The dimer 
formation presumably occurs through intermolecular disulfide bond formation. 
However, some albumin dimers seemed to be formed through non-disulfide 
bonds. These preparations give two protein bands corresponding to two classes of 
dimers. On reduction with P-mercaptoethanol, only one band is broken down to 
monomer while other remains unaltered (Flangen, 1974). The nature of non-
disulfide linkage is not known. The bond is not broken by acidic pH even in the 
concentrated solution of guanidine hydrochloride. The microheterogeneity may 
arise from isolation procedure and by the difference in the amount of bound 
ligands such as lipid, bilirubin and drugs (Foster, 1960; Peterson & Foster, 1965; 
Andersson, 1969; Valmet, 1970). Albumin polymorphism and analbuminemia 
(lack of albumin) are very rare (Dammacco et al, 1980). 
Ligand binding properties 
The remarkable binding properties of albumin account for the role it plays 
in transporting a broad spectrum of endogenous and exogenous ligands in 
vertebral circulatory system. These ligands include fatty acids (Spector, 1986), 
bilirubin (Broderson, 1979; Tayyab & Qasim, 1987), amino acid tryptophan 
(Sollene et al., 1981), hematin (Adams & Herman, 1980), hormones like 
progestrone (Westphal & Harding, 1973) and testosterone (Vermeulen & 
Verdonck, 1968) etc. Many inorganic ions bind to albumin like Ca^ "^ (Pederson, 
1971), Cu^ (^Lau et al., 1974), Ni^ (^Callan & Sunderman, 1973), Hg^ (^Sarker, 
17 
1983), Zn^ (^Gurd & Wilcox, 1956), Mn^ (^Nandekar et al, 1973), Au^ (^Shaw, 
1979) and Al^ ^(Trap, 1983). Several drugs which bind to albumin include 
ibuprofen (Whitlam et al, 1979), novobiocin (Brand & Toribara, 1975), 
indomethacin (Mason & McQueen, 1974), chloropromazine (Sharpies, 1975), 
diazepam (Muller & Wollert, 1973) etc. Albumin binds several organic dyes, 
which include methyl red (Rodkey, 1961), bromocresol green (Peters, 1982), 
bromophenol blue (Tayyab & Qasim, 1990a), Congo red (Tayyab & Qasim, 
1990b) and l-anilino-8-naphthalene sulfonate, a hydrophobic dye (Varela et al, 
1992). Most of these ligands bind reversibly with an association constant of 
10^  to 10^  M-' (Peters, 1985,1992; Kragh-Hansen, 1990; Carter & Ho, 1994). 
Functions of albumin 
Albumin was recognized as the source of 80% of the colloid osmotic 
pressure of blood plasma (Lundsgaard, 1986). It contributes 10% of protein 
nutrition of cells (Peters, 1975) and 100% of the protein effect in the acid-base 
balance of plasma (Figge et al, 1991). Albumin acts as an important 
extracellular antioxidant or free radical scavenger (Halliwell, 1988) probably 
through its thiol group (Sakurai & Miura, 1989). It regulates free calcium 
concentrations (Lohse et al, 1974). Albumin binds polyunsaturated fatty acids 
(Anel et al, 1989) and influences the stability (Haeggstrom et al, 1983), 
biosynthesis (Heinsohn et al, 1987) and conversion of prostaglandins (Dieter et 
al, 1990). It acts as a carrier for long chain fatty acids (Brodersen et al, 1991; 
Cistola & Small, 1991), their acyl Coenzyme A esters (Richards et al, 1990) and 
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mono acyl phospholipids (Robinson et al, 1989) and affects the activity of 
lipases, esterases (Posner & DeSanctis, 1987; Wolfbeis & Gurakar, 1987) and 
carnitine acyltransferase (Richards et al, 1991). It also binds weakly to 
cholesterol (Deliconstantinos et al, 1986), bile acids (Malavolti et al, 1989), 
corticoid hormones (Mendel et al, 1990; Watanabe et al, 1991) and sex 
hormones (Pardridge, 1988) and is involved in the transport of thyroid hormones 
(Mendel et al, 1990) and tryptophan (Herve et al, 1982) through reversible 
binding. It modulates the calcium ion stimulation of gluconeogenesis. It is also 
involved in the transport of pyridoxal phosphate (Fonda et al, 1991), cysteine 
and glutathione (Joshi et al, 1987) by forming a covalent linkage with these 
ligands. It hydrolyses substituted aspirins (Kurono et al, 1984), nitrophenyl 
esters (Kurono et al, 1979) and guanidinobenzoates (Ohta et al, 1988). The 
tight binding of bilirubin to albumin (Knudsen et al, 1986) prevents the passage 
of the former into the central nervous system in newborns (Esbjomer, 1991) and 
helps in its delivery to the liver for conjugation and excretion. It is also infused 
during exchange transfusion to prevent kemicterus in newborn infants. Albumin 
is responsible for the transport and storehousing of many therapeutic drugs in the 
blood stream (Lindup, 1987). Albumin microspheres are useful carriers of 
therapeutic agents (Morimoto & Fujimoto, 1985). Serum albumin is also used in 
peritoneal dialysis, in combating the harmful effect of antibiotics and as 
scavenger of toxic substances and free radicals (Holt et al, 1984). Albumin is an 
important constituent of tissue culture media (Barnes & Sato, 1980). It serves as 
a medium to support growth of microorganisms e.g. bacteria, fiingi and yeasts 
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(Callister et al., 1990; Morrill et al., 1990). It provides physical support against 
mechanical sheer stress in culture by creating more favorable colloid osmolarity 
and viscosity conditions (Peters, 1992). Serum albumin has been used as 
replacement of blood and plasma for the growth of malarial parasites (Nayar et 
al., 1991). Albumin acts as a carrier for chemotactic factors and affects 
phagocytosis by leucocytes and macrophages (Echarti & Maurer, 1989). It 
interacts with cell membrane receptor and thus enhances the intercellular 
adhesion of the neuroretinal cells. Albumin is also a carrier for haptens. DNP-
HSA is often used to test the responsiveness of allergenic systems, such as 
release of histamine from mast cells (Levi-Schaffer et al., 1990). In many 
immunoassays, albumin acts as a protective protein, preventing loss of reactive 
protein and other macromolecules on vessel walls (Miles, 1990). Albumin has 
also been used in preservation of tissues such as human kidney and rat liver 
(Hatzinger & Stevens, 1989; Hellmann et al., 1990). It has been found to support 
several enzymes and membranes through stabilizing them or supporting the 
reaction catalyzed by them. It stabilizes phosphoribosyl pyrophosphate 
synthetase and aminopeptidase and accelerates fatty acyl Coenzyme A 
incorporation into glycerol phosphates. 
Albumin because of its low cost, reproducible quality and availability in 
purest form has been used as a standard for assays of total protein by the method 
of Lowry et al. (1951), biuret and coomassie blue procedures for many decades. 
Albumin serves as a stable molecular weight reference for gel electrophoresis, 
diffiision techniques, sedimentation in ultracentrifugation (Szabolcs & Francia, 
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1989). Albumin is used as a candidate reference material in bilirubin 
determination. Fructosamine-albumin serves to standardize protein-bound 
fructose assays (Podzorski & Wells, 1989) and sialyllacto-N-fiicopentaose-HSA 
is employed as a standard to assay tumor-associated antigens (Masson et al., 
1990). Albumin is used as a test substance for immunochemical labeling reaction 
in electron microscopy (Gagne & Miller, 1987) and in radioiodinated form for 
uptake and digestion by the embryonic yolk sac (Dunton et al., 1988). 
Isomerization 
Serum albumin shows major reversible conformational isomerization with 
change in pH (Luetscher, 1939). Foster studied these earlier observations in 
much greater detail (Foster, 1960; 1977) and classified in the following forms. 
E - - F - - N - - B - - A 
pH of titration: 2.7 4.3 8 10 
'N', for normal form, which is predominant at neutral pH; 'B', for basic form 
occurring above pH 8.0; 'F', for fast migrating form at pH values less than 4.0; 
'E', for expanded form at pH less than 3.5 and 'A', for aged form existing with 
time at pH values greater than 8.0. Most of these isomerizations have been 
studied with BSA, but they apparently occur in a similar fashion with HSA. 
(a) 'F' form: Foster (1977) recognized this form by demonstrating that the 
abrupt discontinuity in titration of BSA with HCl where about 40 carboxyl side 
chains become titrable (Tanford, 1952) at pH 4.0-4.5 coincided with the 
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appearance of a faster migrating or 'F' form, as seen on gel electrophoresis at 
pH 3.0-4.0 (Aoki & Foster, 1957). Geisow & Beaven (1977) proposed that the 
N^F transition involved the unfolding of domain III from the rest of the 
molecule which was later verified by Khan (1986) using proteolytic fragments of 
BSA containing residues 377-582 (Peters & Feldhoff, 1975) whereas no 
conformational changes were found to occur in the fragment containing domains 
I and II during the N=^F transition (Khan & Salahuddin, 1984). Hydrodynamic 
properties such as sedimentation rate, diffusion constant and intrinsic viscosity 
show that the 'F' form is longer and increasingly asymmetrical (Figure 4)(Carter 
& Ho, 1994). Ultrasonic absorption and velocity spectra (Choi et al, 1990) 
exhibited a relaxation frequency near 200 KHz attributed to the expansion of the 
molecule. In addition to the availability of 40 carboxyl groups to titration with 
HCl, 3 to 5 tyrosyl side chains become unmasked in bulky solvent such as 
sucrose (Herskovits & Laskowski, 1962; Steinhardt et al, 1971). There is a loss 
of about 12 binding sites for SDS (Foster, 1960) and a 40-50% increase in ANS 
binding (Foster, 1960; Miller et al, 1991). Helical content decreases from about 
55% to 45% as judged by CD (Era et al, 1983). This form also differs from the 
'N' in being precipitated readily by 3M KCl (Foster, 1977). Carter & Ho (1994) 
proposed that N=^F transition led to the separation of the two halves of the 
molecule, domains I + HA and domains IIB + III from each other under mild 
acidic conditions. These two halves are held together by both hydrophobic and 
salt bridge interactions. Mir & Qasim (1986) have suggested that interaction of 
Figure 4. Ribbon diagrams of serum albumin in its N form, and 
in its proposed F and E forms (Taken from Carter & Ho, 1994). 
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albumin with nearby companion albumin molecules reduces the onset of 
isomerization. 
(b) 'E' form: This was termed as 'E', or expanded form by Foster (1960), which 
occur between pH 3.5-2.5. This form is characterized by the full expansion of the 
molecule within limit of its disulfide bonds. The electron microscopic study 
shows this form as a thread of 21 x 250 A, two third longer than the model at 
neutral pH (Slayter, 1965). The marked increase in intrinsic viscosity indicates 
the rise in hydrodynamic axial ratio from 4 to 9 (Harrington, 1956). The circular 
dichroic studies show the decrease in the 208-268 nm region and an increase 
between 295 and 300 nm (Sogami et al., 1982). The helical content decreases 
from 45% to 35% (Peters, 1985). Fluorescence polarization study shows an 
increase in rotational relaxation time of tryptophans indicating more accessibility 
of these residues to fluorescence quenchers although their emission maximum 
shifts to shorter wavelength (Sogami et al., 1982; Brewer et al., 1987). Carter & 
Ho (1994) have proposed that 'E' form is formed due to the sequential subdomain 
dissociation resulting in the loss of intradomain helices. Acid expansion is fully 
reversible. Increase in ionic strength leads to a decrease in acid expansion of the 
molecule indicating the involvement of ionic forces. Since all carboxyl groups 
are protonated under these conditions, protonation of basic amino acid side 
chains leads to mutual repulsion between domains and subdomains of the 
molecule. The positive charge is distributed uniformly along the structure being 
+34, +36 and +32 on BSA domains I, II and III respectively (Peters, 1996). 
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(c) 'B' form: Titration to pH 9.0 generates the 'B' form or basic form 
(Zurakowski & Foster, 1974). Based on UV difference spectral results at 
287 nm, albumin shows increased exposure of some tyrosine residues (Williams 
& Foster, 1959) in the pH range 7.0 to 9.0. It is characterized by the increased 
accessibility of tyrosine, serine, arginine, isoleucine, glycine, phenylalanine and 
proline residues (Dzafarov, 1991). Tryptophan fluorescence and rotatory 
relaxation time exhibit little change (Era et al, 1990). Small reduction (10%) in 
a-helical content and gain (8%) in P-structure have been found using CD data 
(Wilting et al, 1976; Era et al, 1990). The fluorescent dye ANS shows a 
decrease in rotatory relaxation time from 131 to 114 nanoseconds (Era et al, 
1990). This form is more protonated than 'N' form as evident from the decrease 
in anodic mobility. 
(d) 'A' form: 'A' form or aged form is formed when the albumin is left at pH 
9.0 for 3-4 days in salt free solution (Sogami et al, 1969). The 'A' form is 
characterized by a slower electrophoresis migration rate and by decreased 
solubility in 3M KCl (Nikkei & Foster, 1971). It has been shown to be the result 
of a sulfhydryl catalyzed disulfide interchange reaction (Stroupe & Foster, 1973; 
Era et al, 1990). 'A' form can be prevented by blocking the free thiol of the 
protein or can be induced in the reversibly blocked protein by an external thiol 
reagent (Peters, 1985). 
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Denaturation 
The conformational stability of native albumin has been studied by 
exposing it to extremes of a variety of conditions, including pH, temperature, 
pressure and chemical denaturants. The chemical denaturants include urea and 
its derivatives, GdnHCl, surfactants, cationic detergents and organic solvents 
such as 2-chloroethanol, dioxane and propyl alcohol. 
Denaturation of albumin was followed by measurements of optical 
rotation, intrinsic viscosity, circular dichroism, differential scanning calorimetry, 
urea-gradient gel electrophoresis and light scattering. The denaturation of serum 
albumin is reversible (Wallevik, 1973; Aoki et al, 1974, Reisler et al, 1977) as 
indicated by the capacity of refolded protein to bind specific antibodies, bilirubin 
and palmitate (Teale & Benjamin, 1977; Wichman et al, 1977; Chavez & 
Benjamin, 1978; Johanson et al, 1981). Teale & Benjamin (1977) proposed that 
the denatured albumin molecule with reduced disulfide bonds is capable of 
regaining its native structure after removal of the denaturants by slow oxidation 
of its thiol groups to disulfide bonds. Albumin can withstand 8 M urea or 6 M 
GdnHCl even at 44°C with a temporary loss of helix without any obvious harm 
(Tanford, 1968). However, prolonged or repeated heating or exposure to alkali 
causes dimerization, unfolding and eventual aggregation. Polymerization and 
loss of helix occurs in less than 1 minute when the protein is exposed to 65°C at 
pH 9.0 (Aoki et al, 1973). The process may involve disulfide-bonded loops 
and/or domains (Aoki et al, 1973; Brandt & Andersson, 1976; Wallevik, 1976; 
Wetzel et al, 1980) and can be prevented or delayed by alkylation of the free 
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thiol group. Fatty acid free albumin tends to aggregate more promptly than fatted 
albumin (Brandt & Andersson, 1976; Shrake et al, 1984). Acid-induced 
denaturation of albumin has been discussed under the sub-title 'Isomerization'. 
Effect of solvent and heat on protein conformation is described here. 
(a) Solvent: The most commonly used chemical denaturants, urea and GdnHCl 
denature proteins when present in high concentration by weakening hydrophobic 
as well as polar interactions (Dill & Shortle, 1991). They make water to act as a 
better solvent for nonpolar residues and compete directly for hydrogen bonds. 
The albumin denaturation by urea and GdnHCl has been studied by a number of 
workers (Kauzmann & Simpson, 1953; McKenzie et al, 1963; Katz, 1968; 
Lapanje, 1969; Gordon, 1972; Wallevik, 1972; Nakagaki & Sano, 1972; Katz et 
al, 1973; Aoki et al, 1974; Kawaguchi & Matsushita, 1974; Lapanje & 
Skerjnac, 1974; Taylor et al, 1975; Reisler et al, 1977; Wallevik, 1971; Khan et 
al, 1987). Little changes occur in albumin molecule below 4.0M urea 
concentration (Khan et al, 1987) or 1.8 M GdnHCl (Katz et al, 1973; Wallevik, 
1972; Aoki et al, 1974) followed by stepwise changes upto about 8 M urea 
which includes a rapid initial change followed by molecular expansion (Chmelik 
et al, 1988). The mid point of the optical changes (Chmelik et al, 1988) and 
viscosity increase (Gutter et al, 1957) is about 6 M and 5 M urea respectively. 
The maximum change in reduced viscosity is from 0.14 to 0.20 at pH ~5 and 
doubling of intrinsic viscosity is not attained until 8.0 M urea and near pH 10 
(Frensdorff et al, 1953). The S-S bond cleavage by thiol reagents increases 
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gradually with increasing concentration of urea and the full reduction of the 17 
bonds is achieved in 8 M urea at pH 5.0 (Kolthoff e/ al, 1960). 
Urea-induced denaturation of albumin has been shown to be a two-
step/three state transition with a stable intermediate (Aoki, 1973; Franglen, 1974; 
Brandt & Andersson, 1976; Khan et al., 1987). However, guanidine 
hydrochloride denaturation of HSA has been shown to be a single-step process 
with no intermediate state (Wallevik, 1973). Based on the spectrophotometric 
and fluorimetric data of large fragment (domain II + III) of BSA, Khan et al. 
(1987) proposed that urea causes unfolding of domain III or separation of its 
subdomains at about 4 M urea accompanied by minor changes in domain II. It 
may be noted that this is the same molecular region in which the N=?^ F transition 
occurs at pH 4.0 (see isomerization section). 
The effect of 8 M urea or 4 M GdnHCl (pH 5.0, 25°C for upto 5 days) on 
BSA has been shown to be completely reversible by viscosity, helical content 
and nonavailability of S-S bonds for reduction (Kolthoff e? al., 1960). Albumin 
dissolves readily in many organic solvents at low pH accompanied by molecular 
expansion that returns to native state on removal of the solvent whereas at neutral 
pH, albumin undergoes aggregation in ethanol, which may be protected by 
blocking the thiol group (Rosenberg et al., 1962). Less polar organic solvents 
that are miscible with water denature the albumin molecule. Anionic detergents 
like sodium dodecyl sulfate denature the albumin and increase accessibility of 
S-S bonds to reduction. Cationic detergents can also increase S-S exchange. 
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(b) Heat: Albumin is more stable to heat than any other plasma proteins. A total 
of 17 disulfide bridges, which are exclusively intra-domain and conserved across 
species, contribute towards HSA's impressive thermostability (He & Carter, 
1992). Irreversible loss of helical content and polymerization occur when the 
albumin molecule is exposed for 1 minute to 65°C at pH 9.0 (Aoki et al, 1973) 
or exposed to 8M urea or 6M GdnHCl at 44°C (Tanford, 1968). A loss of a-helix 
(61% to 44%) and a gain of P-structure (from 6%o to \6%) occur between 62°C 
and 75°C as judged by CD, infrared and laser Raman studies (Clark et al, 1981). 
Prolonged or intense heating causes dimerization, unfolding and eventual 
aggregation (Roelands, 1974). These changes occurred through a series of 
intermediates, which may indicate the serial involvement of disulfide bonded 
loops or domains (Aoki et al, 1973; Brandts & Andersson, 1976; Wallevik, 
1976; Wetzel et al, 1980). The availability of S-S bonds increases from 5% at 
60°C to 47% at 100°C (Alexander & Hamilton, 1968). Effects of heat upto 45°C 
(Takeda et al, 1989) or to 20% of maximal denaturation (Wetzel et al, 1980) are 
fiilly reversible whereas 60%o reversibility is foimd after exposure to 80°C. 
Temperature-induced aggregation is sensitive to the protein concentration as Tm 
for intramolecular helix is 5°C lower at 0.50 mg/ml than at 0.05 mg/ml and the 
formation of 26-36 s aggregates at 80°C is 100%o at 10 mg/ml as compared to 
48%) at 0.50 mg/ml. Irreversible aggregation to 75°C can be prevented by 
blocking the thiol group with N-ethylmaleimide (Jensen et al, 1950). 
The technique of differential scanning calorimetry proved much helpful in 
exploring the mechanism of heat denaturation (Yamasaki et al, 1990). Defatted 
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and SH-blocked BSA exhibits two peaks on increasing the temperature, 
indicating a transitional stage. The increase in ionic strength in the neutral to 
alkaline pH range (5.6-9.0) resulted in an increased enthalpy. Albumin is 
stabilized in the neutral alkaline pH range by the presence of NaCl but 
destabilized in the acidic pH range (Yamasaki et al, 1990). With 0.2 M NaCl, no 
change in fluorescence of HSA tryptophan or bound ANS (Niamaa et al, 1984) 
takes place up to 50°C. The thermostability in salt solutions increases with more 
chaotropic species, chlorate > isothiocyanate > bromide > chloride (Damodaran, 
1989). Yamasaki et al. (1991) suggested that heat induced electrostatic repulsive 
forces in the region between Argl85 and Arg217. The biphasic nature of 
temperature-induced denaturation curves is the result of the removal of 
stabilizers. Octanoate, long chain fatty acids and N-acetyl-L-tiyptophan protect 
HSA from denaturation at 60°C (Edsall, 1984; Shrake & Ross, 1988). Octanoate 
provides a 22°C additional heat stability and palmitate 15°C over defatted 
albumin. Heat-induced denaturation of fat-free albumin is dependent on its 
concentration whereas denaturation of fatted albumin is not (Ross & Shrake, 
1988). Covalent changes in the amino acid residues of the protein occur when the 
protein is exposed to extreme conditions of heat and time especially under 
alkaline range. Exposure to UV radiation also results in some covalent changes 
(Maurer, 1959). 
The folding of a protein from its non-native state to its specific 
biologically active conformation has generally been assumed to occur through a 
pathway or a set of pathways in order to fold in a finite time scale (Dill & Chan, 
30 
1997). Therefore, the study of conformation and intermediates formed in the 
folding pathway of proteins has become central to the study of protein folding 
(Kim & Baldwin, 1990; Redfield et al, 1994) 
Acid denaturation of several proteins results in a denatured state that is 
often less unfolded than the completely unfolded form, obtained either in 9 M 
urea or 6 M GdnHCl (Dill & Shortle, 1991; Matthews, 1993). In acid 
denaturation, the major driving force for unfolding is intramolecular charge 
repulsion which may fail to overcome the interactions favoring folding such as 
hydrophobic forces, disulfide bonds, salt bridges and metal ion-protein 
interactions (Fink et al, 1994). The exact mechanism of a given protein at low 
pH is a complex interplay between a variety of stabilizing and destabilizing 
forces. It has been shown that certain proteins under the conditions of low pH 
have compact dimension, abundant secondary structure and largely disordered 
tertiary structure, which are the characteristics of 'molten globule' state, which is 
considered to be a general intermediate in the folding pathway of proteins 
(Kuwajima, 1989; Ptitsyn, 1990). Most of the proteins for which a molten 
globule intermediate has been characterized are small monomeric, single domain 
proteins (Kim & Baldwin, 1990; Matthews, 1993; Ogasahara & Yutani, 1994; 
Kay & Baldwin, 1996; Arai & Kuwajima, 1996) whereas multidomain and 
oligomeric proteins remain relatively little explored (Jaenicke, 1991). Since the 
folding/unfolding of such proteins are accompanied by the association/ 
dissociation of subunits/domains, the processes are much more complicated than 
those of monomeric and/or single domain proteins and such studies can yield 
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additional insight into the interdependence/dependence of folding of subunits/ 
domains of oligomeric and multidomain proteins (Price, 1994; Jaenicke, 1996; 
1998). 
More recently much emphasis has been laid towards biological 
importance of non-native conformations of proteins ranging from various 
denatured conformations to aggregated forms (Beerman et al, 1998; Prusiner et 
al, 1998; Sigler et al, 1998; Dobson, 1999; ElUs, 1999; Hamada et al, 2000). 
One such intermediate is the molten globule state. One key feature of the molten 
globule model is that the protein intermediates formed from different proteins 
will have common structural properties. However, it has been shown in a number 
of studies (Fink et al, 1997; Alexandrescu et al, 1993) that the molten globule 
model is incorrect and that each protein will potentially have partially folded 
intermediates with regions of unique structure, suggesting that each protein has 
its own amino acid sequence with its unique folding pathways. 
The structural stability of proteins is a reflection of the overall molecular 
interactions among all amino acid residues. To understand the interactions 
governing the formation of the three dimensional structure from the amino acid 
sequence, studies were focused on the characterization of denatured state and 
unfolding/refolding intermediates under several non-native conditions such as 
high ionic strength, extremes of pH, organic solvents, temperature variation and 
mild denaturing conditions (Kuwajima, 1989; Goto et al, 1990; Dill & Shortle, 
1991; Fink et al, 1994; Konno, 2000). The formation of intermediates during 
protein folding is well established as a common feature of all but the simplest of 
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proteins (Roder & Colon, 1997). Much progress has been made in characterizing 
these intermediates, which include both transient species detected in kinetic 
experiments (Kim & Baldwin, 1990; Schmid, 1992; Matthews, 1993; Evans & 
Radford, 1994; Plaxco & Dobson, 1996) and stable species that can exist at 
equilibrium under a variety of conditions where the native state is destabilized 
(Kuwajima, 1989; Uversky & Ptitsyn, 1994; Dobson, 1992; Ptitsyn, 1995). The 
folding mechanism of multidomain proteins is more complex because of the 
autonomous folding of domains and sub-domains and their subsequent 
interaction to produce the native state (Goldberg, 1969 Wetlaufer, 1973; 1981; 
Janin & Wodak, 1983; Jaenicke, 1996). Intermediates of a protein including 
molten globules can be stabilized under equilibrium conditions in mild 
denaturing medium or by introducing organic solvents such as 2,2,2-
trifluoroethanol (TFE) (Kuwajima, 1989; 1996; Hughson et al, 1990; Buck et 
al, 1993). Alcohols strengthen hydrogen bonding in proteins, leading to 
increased a-helical content (Herskovits et al, 1970; Galat, 1985; Nelson & 
Kallenbach, 1986) but destabilize tertiary structure by influencing the 
hydrophobic interactions within the protein (Herskovits et al, 1970; Shiraki et 
al, 1995). The effect of alcohols, particularly TFE, on the conformation of 
several intact single domain proteins has been examined and its comparison with 
the molten globule intermediate obtained under aqueous conditions has been 
made (Buck et al, 1993 Alexandrescu et al, 1994). These studies suggest that 
TFE stabilizes an open-helical structure, in which the interaction between helical 
segments are weak and many hydrophobic groups are exposed to the solvent. The 
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open-helical structure is distinct from the compact molten globule state, which is 
stabilized by the weak but significant inter-helical hydrophobic interaction 
(Nishii et al, 1994; Hagihara et al., 1994). 
In this thesis, we have shown the acid-denatured state of human serum 
albumin (HSA) at low pH (2.0). The effect of various alcohols has been studied 
on the aforesaid state. Also, the effect of vaious alcohols on urea-induced folding 
has been investigated and discussed. 
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MATERIALS AND METHODS 
A. MATERIALS 
1. Proteins 
Essentially fatty acid-free HSA, type A-1887 (Lot 14H9319) and BSA, 
type A-6003 (Lot 42F9365) were obtained from Sigma Chemical Company, MO, 
USA. HSA monomer was purified by Sephadex G-lOO gel chromatography and 
homogeneity of the purified preparation was checked by polyacrylamide gel 
electrophoresis (Figure 5). This preparation was used throughout these studies. 
2. Chromatographic media 
Sephadex G-lOO (Lot 54H0484) and blue dextran 2000, type D-5751 (Lot 
62H0796) were the products of Sigma Chemical Company, MO, USA. 
5. Reagents used in electrophoresis 
Acrylamide (Bxcrystallised) and N, N'-methylenebisacrylamide (3x 
crystallized) were purchased from Sisco Research Laboratories Pvt. Ltd., 
Mumbai, India. Trizma base (tris [hydroxy methyl] aminomethane), type T-6791 
(Lot 14H5717), dimethyldichlorosilaiie, type D-3879, glycine, type G-8898 (Lot 
113H1255) and coomassie brilliant blue R 250, type B-0149 (Lot 13H5002) were 
obtained from Sigma Chemical Company, MO, USA. Ammonium persulphate, 
sucrose, glycerol, acetic acid and methanol were procured from Qualigens Fine 
Chemicals, Mumbai, India. 2-Mercaptoethanol and riboflavin were purchased 
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Figure 5. Gel chromatography of HSA on Sephadex G-lOO 
column (100 x 2.36 cm). The inset shows the electrophoretic 
pattern of the isolated monomer on a 8 % (w/v) polyacrylamide 
gel at pH 8.2. 
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from E. Merck, Darmstadt, Germany. N,N,N',N'-tetramethylethylene-diamine 
(TEMED) was the product of Fluka AG, Switerzerland. Bromophenol blue was 
the product of B.D.H., Poole, England. 
4. Reagents used in protein estimation 
Analytical grade samples of copper sulphate, sodium potassium tartarate, 
sodium carbonate, orthophosphoric acid, lithium sulphate, sodium molybdate, 
sodium tungstate and hydrochloric acid were obtained from Qualigens Fine 
Chemicals, Mumbai, India. Liquid bromine was procured from Sigma Chemical 
Company, MO, USA. Folin-phenol reagent was prepared according to the 
standard procedure (Folin & Ciocalteu, 1927). Copper reagent was prepared fresh 
by mixing 1 volume of 4% (w/v) sodium potassium tartarate to 100 volume of 
4% (w/v) sodium carbonate and finally adding 1 volume of 2% (w/v) copper 
sulphate. 
5. Reagents used in denaturation studies 
Ultra-pure urea, type U-0631 (Lot 126H1454) and guanidine 
hydrochloride (GdnHCl), type G-7153 (Lot 85H0121) were the products of 
Sigma Chemical Company, MO, USA. Constant boiling hydrochloric acid was 
prepared by the method of Foulk & HoUingsworth (1923). 
6. Alcohols used in refolding studies 
1,1,1,3,3,3-hexafluoroisopropanol (HFIP), type H-8508 (Lot 67H3485) 
and 2,2,2-trifluoroethanol (TFE), type T-8132 (Lot 84H3423) were procured 
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from Sigma Chemical Company, MO, USA. Methanol, ethanol, isopropanol, 
tert-butanol and 2-chloroethanol used were of highest purity grade. 
7. Other reagents 
N-Acetyl-L-tryptophanamide (NATA), type A-6501 (Lot 53H1590) and 
l-anilino-8-naphthalene sulfonate, type A-3125 (Lot 86H2608) were obtained 
from Sigma Chemical Company, MO, USA. Sodium dihydrogen phosphate, 
disodium hydrogen phosphate, sodium hydroxide, potassium dichromate, 
potassium hydrogen phthalate, sodium tetraborate, potassium permanganate were 
of analytical grade and obtained from Qualigens Fine Chemicals, Mumbai, India. 
Sodium azide was the product of S.D. Fine Chemicals, Mumbai, India. 
8. Miscellaneous 
Dialysis tubings of different sizes were purchased from Sigma Chemical 
Company, MO, USA. Millipore filters (pore size 0.45 i^m) were purchased from 
Millipore (India) Pvt. Ltd., Bangalore, India. Whatman filter papers (No. 1) were 
the product of Whatman International Ltd, Maidstone, England. Parafilm 'M' was 
obtained from American Can Company, CT, USA. Solid glass beads (5 mm 
diameter) and glass wool were obtained from S.D. Fine Chemicals, Mumbai, 
India. pH indicator papers were supplied by Qualigens Fine Chemicals, Mumbai, 
India. All glass distilled water was used throughout these studies. All the 
experiments were performed at room temperature (~25°C) unless otherwise 
stated. 
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B. METHODS 
/. Determination of protein concentration 
Protein concentrations were determined either spectrophotometrically or by 
the method of Lowry et a/. (1951) using bovine serum albumin as the standard. 
(a) Spectrophotometric method 
Protein concentration was determined from the value of specific extinction 
coefficient (E'°'^ °icm= 5.30 and 6.61 for HSA and BSA respectively) by measuring 
the absorbance of protein solution at 280 nm (Pace et al., 1995) on a Cecil double 
beam spectrophotometer, model CE 594. 
(b) Method of Lowry et at. (1951) 
Increasing volumes of stock protein solution (0.5 mg/ml) in the range of 
0.1-1.0 ml were taken in different test tubes and the volume in each tube was 
made to 1.0 ml, if required, with 0.06 M sodium phosphate buffer, pH 7.0. To 
each test tube, 5.0 ml of freshly prepared copper reagent was added and the 
contents were mixed well. After 10 minutes of incubation at room temperature, 
1.0 ml of diluted Folin-phenol reagent was added and mixed thoroughly. The 
tubes were incubated for 30 minutes at room temperature and the color intensity 
was read at 700 nm against a suitable blank prepared in the same way as that of 
test solution except that instead of protein solution, 1.0 ml of buffer was taken. A 
calibration curve, thus obtained, between absorbance at 700 nm and amount of 
protein yielded the following straight line equation (Figure 6): 
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Figure 6. Standard curve for the determination of protein 
concentration by the method of Lowry et al. (1951). 
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(Absorbance)7oo nm = 1 -9 (amount of protein, mg) + 0.05 (1) 
2. Preparation of constant boiling hydrochloric acid 
Constant boiling hydrochloric acid was prepared by the method of Foulk 
& HoUingsworth (1923). About 300 ml of concentrated hydrochloric acid 
(analytical grade) was diluted to 600 ml with water and distilled in a flask fitted 
with a condenser. The first 20 ml of the distillate was discarded while the next 
500 ml was collected and fiirther redistilled at a constant temperature of 109°C. 
About 3/4 part of the distillate was discarded and the constant boiling fraction 
was collected in a dry flask. The distillation was discontinued when about 50-60 
ml residue was left in the distillation flask. 
3. pH measurements 
ELICO digital pH meter, model LI 610 using a PPC's combined electrode, 
type CL-51 consisting of glass and reference electrodes in a single entity, was 
used for pH measurements. The least count of the pH meter was 0.0IpH unit. 
The pH meter was routinely calibrated at room temperature with either 0.05 M 
potassium hydrogen phthalate buffer, pH 4.0 in the acidic range or 0.01 M 
sodium tetraborate buffer, pH 9.2 in the alkaline range. 
4. Polyacrylamide gel electrophoresis (PAGE) 
Polyacrylamide gel electrophoresis was performed in 8% (w/v) 
polyacrylamide gel using 0.02 M tris-glycine buffer, pH 8.2, ionic strength 0.02 
by the method of Laemmli (1970). About 20 ^g of the protein was loaded in 
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10 lull sample buffer and a current of 4 mA per well was applied for nearly 2 
hours. The gel was stained with the staining solution containing 0.25% (w/v) 
coomassie brilliant blue in 40% (v/v) methanol and \0% (v/v) acetic acid and 
destained in 10% (v/v) acetic acid solution containing 10% (v/v) methanol at 
37°C. 
5. Gel chromatography 
A column of Sephadex G-100 (100 x 2.36 cm) was packed according to 
the published procedure of Tayyab et al. (1991) and equilibrated with 0.06 M 
sodium phosphate buffer, pH 7.0. Uniformity of the column was checked by 
passing a band of blue dextran (10 mg/2 ml). The elution volume of blue dextran 
gave the void volume (Vo) of the column and was found to be 156 ml. The inner 
volume (Vi) of the column was determined as 251 ml after passing potassium 
permanganate solution. About 20-40 mg of commercial albumin preparation 
(defatted HSA) in 4-8 ml of 0.06 M sodium phosphate buffer, pH 7.0 was loaded 
on the column and eluted with the same buffer at a flow rate of 
20-25 ml/hr in 5.0 ml fractions. The protein in each fraction was monitored 
spectrophotometrically by measuring absorbance at 280 nm. Fractions 
representing albumin monomer were pooled, concentrated and stored at 4°C. 
6. Circular dichroism (CD) spectroscopy 
CD measurements were made on a Jasco spectropolarimeter, model J-720, 
attached with a microcomputer. The instrument was calibrated with 
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d-10-camphorsulphonic acid. All CD measurements were carried out at 25°C 
with a thermostatically controlled cell holder attached to a NESLAB's RTE-110 
waterbath with an accuracy of ± 0.1 °C. Spectra were collected with a scan speed 
of 20 nm.min"' and with a response time of 1 sec. Each spectrum was the average 
of four scans. Far-UV CD spectra were taken at a protein concentration of 
1.8-4.7 |iM with a 1-mm pathlength cell and the near-UV CD spectra were 
measured at 18-26 i^M concentration with a 10-mm pathlength cell. The results 
are expressed as mean residue ellipticity (MRE) in deg.cm .^dmol'*, which is 
defined as: 
MRE = Gobs (mdeg)/IO x n x 1 x Cp (2) 
where 9obs is the CD in millidegrees, n is the number of amino acid residues 
(585), / is the pathlength of the cell and Cp is the mole fraction. The a-helical 
content of HSA was calculated from the MRE value at 222 nm using the 
following equation as described by Chen et al. (1972): 
% helix = (MRE222 - 2340/30300) x 100 (3) 
For temperature transition studies, a water-jacketed 0.1-mm pathlength 
cell was used for far-UV CD and a water-jacketed 10-mm pathlength cell was 
used for near-UV CD attached to the RTE-110 waterbath interfaced with the 
microcomputer. The same protein solution (18 \)M) was used in both near-UV 
and far-UV CD measurements. In transition studies, the temperature was raised 
in small increments and the change in spectral signal noted. Each reading at 
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desired temperature was recorded after an incubation time of 20 min. at that 
temperature. 
7. Fluorescence spectroscopy 
Fluorescence measurements were carried out on a Shimadzu 
spectrofluorometer, model RF-540, equipped with a data recorder DR-3. The 
fluorescence spectra were measured at a protein concentration of 1.8 i^M with a 
1-cm pathlength cell. The excitation and emission slits were set at 5/10 nm each. 
For ANS fluorescence in the ANS-binding experiments, the excitation 
wavelength was set at 380 nm and the emission spectra were taken in the range 
400-600 nm or at a fixed wavelength of 470/480 nm. Intrinsic fluorescence was 
measured by exciting the protein solution at 280 nm and emission spectra were 
taken in the range 300-400 nm. 
8. Acid-induced unfolding ofHSA 
HSA solutions, of varying pH, were prepared by adding different volumes 
of HCl/water mixtures of different concentrations (pH values) to a protein stock 
solution (9 \xM) such that the final volume in each tube was 5.0 ml. These tubes 
were incubated for 30 min. at 25°C. The pH values of the samples were found to 
lie within 0.1 pH unit when taken before and after the CD and fluorescence 
measurements. 
For ANS-binding studies, to a protein solution incubated with varying 
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concentrations of HCl, a concentrated stock solution of ANS was added to obtain 
a final concentration of 125 ^M and 1.8 |iM for ANS and protein respectively. 
9. Conformational transitions 
To study the effect of alcohols on the conformation of acid-denatured 
HSA at pH 2.0, increasing volumes of different alcohols were added to 1.0 ml of 
HSA stock solution (8-10 jiiM) followed by the addition of different volumes of 
100 mM glycine-HCl buffer, pH 2.0 so as to get the desired molarity of alcohols. 
The final volume in each tube was 5.0 ml. These tubes were incubated for 30 min 
at 25°C. The pH of the incubation mixture was measured and found to lie within 
±0.1unitofpH2.0. 
For ANS binding studies, to a protein solution in 10 mM glycine-HCl 
buffer, pH 2.0, incubated with varying concentrations of alcohols, a concentrated 
stock solution of ANS was added to get a final concentration of 125 nM and 
1.8 |iiM for ANS and protein respectively. 
10. Acrylamide quenching experiments 
In the acrylamide-quenching experiments, aliquots of 5 M (IM for NATA 
experiments) acrylamide stock solution were added to a protein stock solution 
(15 |iM) to achieve the desired acrylamide concentration. The final concentration 
of protein was 1.5 |iM. Excitation was set at 295 nm in order to excite tryptophan 
fluorescence only, and the emission spectrum was recorded in the range 300-400 
nm. The slit width was set at 10 nm for both excitation and emission. The 
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decrease in fluorescence intensity at m^ax was analyzed according to the 
Stem-Volmer equation (Eftink and Ghiron, 1982): 
Fo/F = 1 + Ksv[Q] (4) 
where FQ and F are the fluorescence intensities at an appropriate wavelength in 
the absence and presence of a quencher (acrylamide) respectively; Ksv is the 
Stem-Volmer constant for the collisional quenching process and [Q] is the 
concentration of the quencher. K^ v values were calculated by the least-squares 
analysis of the linear early part of the Stem-Volmer plot of Fo/F versus [Q]. 
11. Viscosity measurements 
Viscosity data were obtained using a calibrated Cannon-Fenske 
viscometer (Cannon Instmment Co., PA, USA) with a flow time of about 400 sec 
for distilled water at 25°C. The temperature of the viscometer was maintained at 
25+0.1°C by dipping it in a glass tank filled with distilled water and attached to a 
waterbath. The time of fall was recoded with a stop watch reading to 0.1 sec. 
Each solution was filtered through a 0.45 fim millipore filter. The reduced 
viscosity of a protein is defined as (Tanford, 1955): 
rired = [(t-to) / toC] + [ ( 1 - V2 Po) / Po] (5) 
where to is the time of fall of the solvent; t is the time of fall of the protein 
solution; c is the protein concentration in g/ml; Vi is partial specific volume of 
protein taken as 0.734 (Ahmad 8c Salahuddin, 1974) and Po is the density of the 
solvent. Intrinsic viscosity was obtained by linear extrapolation, by the method of 
least squares, of reduced viscosity to zero protein concentration. The viscosity 
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measurements were made at four different concentrations ranging from 2 to 8 
mg/ml. 
12. Unfolding / refolding studies 
Solutions for unfolding and refolding studies were prepared from 
solutions for unfolding and refolding studies were prepared from stock solutions 
of protein and denaturants (urea and GdnHCl) in 0.06M sodium phosphate 
buffer, pH 7.0. In unfolding experiments, to a fixed volume of the stock protein 
solution, different volimies of buffer were added first and denaturant was added 
last so as to get the desired concentration of denaturant. A similar procedure was 
employed in preparing the solutions for refolding experiments with the exception 
that the protein was first denatured by adding denaturant solution, and then 
diluted with buffer. The final mixture for both unfolding and refolding 
experiments was incubated for 12 hr at 25°C before CD and fluorescence 
measurements. 
13. Analysis of data 
The pre- and post-transition baselines were treated by linear extrapolation 
(Tanford, 1970; Pace, 1986) and the unfolding curves for the N^D fransition 
were normalized to the apparent fraction of the unfolded form, FD, using the 
following equation. 
FD=(Y-YN)/(YD-YN) (6) 
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where Y is the observed variable parameter and YN and YD are the values of the 
variable characteristic of the folded and unfolded conformations, respectively. 
The difference in free energy between the folded and unfolded states, AG, is 
given by the following equation: 
AG = -RT In KD = -RT In FD/(1-FD) (7) 
where different terms have their usual significance (Muzammil et al., 2000). 
For the unfolding transition, N=^I—D where I is an intermediate state, each 
step may be assumed to follow a two-state mechanism. The fraction of the 
intermediate state, Fj in the reaction, N=^I can be given as: 
F I = ( Y - Y N ) / ( Y I - Y N ) (8) 
where FI + FN=1 
Similarly, the fraction of denatured state, FD in the reaction; I ^ D can be given 
as: 
FD=(Y-YI) / (YD-Y, ) (9) 
where FD + Fi =1 
Values of equilibrium constant and free energy for the above transitions can be 
obtained in the following way. 
For N=?^ I transition, 
K, = Fi/(l-Fi) (10) 
and 
AGi = -RTlnKi (11) 
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For I=^D transition 
KD=FD/(1-FD) (12) 
and 
AGD=-RTlnKD (13) 
A least squares analysis of the data of AG as a fiinction of denaturant 
concentration [D], was used to fit the data to the following equation for the 
determination of AG 2 , the free energy change in the absence of urea. 
AG = AG 2 -m[D] (14) 
where m is a measure of the dependence of AG on denaturant concentration in 
cal.mol"'. M'^ 
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S- Ki I' t'' 
RESULTS AND DISCUSSION 
1. Acid-induced transition ofHSA 
Figures 7 and 8 illustrate the acid-induced denaturation of HSA as followed 
by measuring ellipticity in the far-UV region at 222 nm and by ANS fluorescence 
respectively. The CD spectrum of a protein in the far-UV region was used to 
probe the conformation of the polypeptide backbone, whereas ANS, a 
hydrophobic dye that binds to exposed hydrophobic regions of partially folded 
proteins, was used to monitor these hydrophobic regions as described previously 
(Stryer, 1965; Johnson & Fersht, 1995). No apparent change was noted in 
ellipticity measurements at 222 nm between pH 6.5 and 4.0, but when the pH 
was decreased below 4.0, a marked decrease in ellipticity to a minimum value at 
around pH 2.1 was observed which remained unchanged down to pH 1.8. A 
further decrease in the pH below 1.8 resulted in a second transition, which 
corresponded to the formation of secondary structure and tailed off at pH 1.3. 
The loss of secondary structure in the first transition was -30% as calculated on 
the basis of the difference in ellipticity at 222 nm between native and the 
denatured state (7M GdnHCl) taken to be 100%. However, in the second 
transition, 7% of the secondary structure re-formed. When the effect of pH was 
evaluated by ANS fluorescence, a gradual increase in fluorescence intensity was 
observed on decreasing the pH below 5.0, reaching a maximum at around pH 2.5, 
whereas no change in ANS fluorescence was observed in the pH range 6.8-5.0. 
Decreasing the pH further below 2.0 led to a gradual decrease in the ANS 
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Figure 7. pH-dependence of MRE at 222 nm of HSA at 25''C. 
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Figure 8. pH-dependence of ANS fluorescence of HSA at 25°C. 
The excitation was set at 380 nm and fluorescence was measured 
at 470 nm. 
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fluorescence, which tailed off at pH 1.1. A red shift of 10 nm (from 470 nm to 
480 nm) was noticed on decreasing the pH from 4.5 to 2.5, which remained 
constant up to pH 2.0 and decreased to 474 nm on decreasing the pH below 2.0. 
The observed red shift in emission maxima and increase in ANS fluorescence 
within the pH ranges 4.5-2.5 and 5.0-2.5, respectively, were indicative of 
exposure of hydrophobic regions to the solvent. The loss of some secondary 
structure as reflected by the decreased ellipticity at 222 nm within the pH range 
4.0-2.1, yielded some hydrophobic regions available for ANS binding. 
Interestingly, below pH 2.0, another transition, characterized by the formation of 
secondary structure specified by the increase in ellipticity and decrease in ANS 
binding as well as the blue shift, was observed which was complete at pH 1.1. 
The transition curves obtained both from ellipticity measurements at 222 nm and 
ANS fluorescence showed a cooperative transition with no apparent intermediate 
state. These results are in close agreement with those reported earlier (Lee & 
Hirose, 1992), which also indicated no intermediate state. These resuhs also 
suggest that the protein's tertiary structure was more sensitive to pH change than 
the secondary structure, as the transition monitored by ANS fluorescence started 
around pH 5.0 whereas that assessed by ellipticity measurement at 222 nm 
started around pH 4.0. These data are in accordance with previous results on 
acid-induced unfolding of HSA (Lee & Hirose, 1992) in which more unfolding 
was observed below pH 4.0 reaching a maximum at pH 2.1 and which was 
partially restored at pH values below 2.0. A shift in the point of transition 
observed in this study (-4.0) from the native to the denatured state compared 
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with the value (pH 5.0) observed previously (Wallevik, 1973) can be explained 
by salt effect (Fink et al, 1994), because, in the earlier study, transition was seen 
in the presence of 0.2 M KCl (Wallevik, 1973). Partial restoration of secondary 
structure at pH 1.1, as observed by the increase in ellipticity, can be ascribed to 
the anion-induced folding (Goto et al, 1990), which decreased the number of 
hydrophobic patches resulting in less binding of ANS. 
2. Characterization of acid-denatured state atpH 2.0 
In order to establish whether the protein state observed at pH 2.0 
represented the extended state (E state) as reported earlier (Foster, 1960; Peters, 
1985; He & Carter, 1992), various characteristics like far-UV and near-UV CD 
spectra, ANS binding, thermal transition, intrinsic fluorescence, acrylamide 
quenchmg and intrinsic viscosity of HSA at pH 2.0 were compared with those 
obtained at pH 6.0 (native state) and in the GdnHCl-denatured state. 
(i) Far-UV CD: Far -UV CD spectrum is especially useful in the conformational 
studies of proteins since it provides a qualitative measure of the average 
secondary structure content. Figure 9 depicts the far-UV CD spectra of HSA in 
the native state (pH 6.0), the acid-denatured state (pH 2.0) and the GdnHCl-
denatured state (7 M) in which the protein is considered to exist in a random coil 
conformation (Dill & Shortle, 1991). The curve obtained, for the native state is 
characterized by the presence of two minima, one at 208 nm and the other at 222 
nm, characteristic of a-helical structure. HSA in the native state contained 
-25000 
200 250 
Wavelength (nm) 
Figure 9. Far-UV CD spectra of native HSA (curve 1), acid-
denatured HSA at pH 2.0 (curve 2) and HSA in 7M GdnHCl 
(curve 3). 
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around 57% a-helical structure (Table 3) as calculated from the ellipticity value 
at 222 nm by the method of Chen et al. (1972), which is in agreement with the 
value reported by other workers (Reed et ah, 1975). The spectrum of the acid-
denatured state retained all the elements of secondary structure, although there 
was a decrease in the ellipticity value, indicating the loss of -15% a-helical 
structure from the native state. HSA in the presence of 7 M GdnHCl, lost all the 
elements of secondary structure as can be seen in Figure 9 (see also Table 3). 
(ii) Near-UV CD: Figure 10 shows the near-UV CD spectra in the 250-300 nm 
range for the native state (pH 6.0), the acid-denatured state (pH 2.0) and in 7M 
GdnHCl. These spectra were used to probe the asymmetric environment of the 
protein's aromatic amino acids. The near-UV CD spectra for the native state 
showed two minima at 262 nm and 268 nm and shoulders at 275 nm and 292 nm, 
characteristic of disulfide and aromatic chromophores (Lee & Hirose, 1992). In 
the acid-denatured state, there was a loss of signal and fine structure at 275 nm 
and 292 nm; nonetheless the protein retained the two minima at 262 and 268 nm. 
There was complete disappearance of all minima in 7 M GdnHCl. A comparison 
of near-UV and far-UV CD spectra of acid-denatured HSA with that of native 
and GdnHCl-denatured HSA (Table 3) shows that the acid-denatured form 
retained a significant amount of secondary structure as well as a major proportion 
of tertiary structure. 
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Table 3 
Some physical properties of HSA 
Variable Native state Acid-denatured GdnHCl-denatured 
state state 
MRE at 222 nm 
(deg.cm^.dmor') 
MRE at 262 nm 
(deg.cm .^dmor^) 
[rj] (cc/g) 
% helix'' 
m^ax (nm) 
(tryptophan fluorescence) 
ANS fluorescence 
(relative fluorescence) 
Cooperativity 
(thermal transition) 
19,800 
123 
3.9 
-57 
340 
14 
Yes 
15,100 
69 
8.4 
-42 
328 
81 
No 
3,700 
37 
22.9' 
-4.5 
350 
-
-
'Taken from Tanford (1967) 
'' Calculated by the method of Chen et al (1972) 
250 300 
Wavelength (nm) 
Figure 10. Near-UV CD spectra of native HSA (curve 1), acid-
denatured HSA at pH 2.0 (curve 2) and HSA in 7M GdnHCl 
(curve 3). 
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(iii) ANS binding: Exposure of the hydrophobic surface to solvent in the acid-
denatured state was studied by ANS binding. Binding of ANS to the hydrophobic 
regions of proteins results in an increase in fluorescence intensity (Stryer, 1965), 
which has been widely used to detect the molten globule states of different 
proteins (Engelhard & Evans, 1995). Figure 11 represents the fluorescence 
spectra of ANS in the 400-600 nm wavelength range in the presence of native 
and acid-denatured protein. As can be seen, binding of ANS to the acid-
denatured state at pH 2.0 produced a large increase (six fold, compared to the 
native HSA) in fluorescence intensity (Table 3) accompanied by a shift in 
spectral maximum from 470 to 480 nm, indicating exposure of hydrophobic 
regions of the protein molecule on acidification. Thus it appears that the acid-
denatured state, although it retained a significant amount of secondary and 
tertiary structure, had sizeable amounts of exposed hydrophobic region. 
(iv) Thermal transition: Figures 12 and 13 show the temperature-induced 
unfolding of the native HSA at pH 6.0 as well as acid-denatured HSA at pH 2.0 
by ellipticity measurements in the far-UV region at 222 nm and in the near-UV 
region at 262 nm, respectively. The thermal unfolding of the native protein as 
seen in the far-UV region at 222 nm and in the near-UV region at 262 nm is a 
cooperative process (Table 3). In the far-UV region, the transition started at 40°C 
whereas in the near-UV region it began at 60°C, suggesting that secondary-
structural changes are more sensitive to temperature than tertiary structural 
changes. On the other hand, thermal transition of the acid-denatured protein at 
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Figure 11. Fluorescence spectra of ANS bound to native HSA at 
pH 7.0 (curve 1) and acid-denatured HSA at pH 2.0 (Curve 2). 
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Figure 12. Temperature-induced transition of native HSA at pH 
7.0 (O) and acid-denatured HSA at pH 2.0 (•) as followed by 
measuring MRE at 222 imi. 
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Figure 13. Temperature-induced transition of native HSA at pH 
7.0 (O) and acid-denatured HSA at pH 2.0 (•) as followed by 
measuring MRE at 262 nm. 
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pH 2.0, as seen in the near-UV and far-UV regions, is a continuous non-
cooperative process (Table 3). Maximum ellipticity of acid-denatured HSA was 
found at 0°C in both the near-UV and far-UV regions, which decreased 
continuously up to 90°C and then tailed off. In view of the gradual transition 
associated with the conformation containing only loosely ordered secondary 
structure (Carra et ai, 1994), and lack of a cooperative thermal unfolding 
transition associated with the molten globule state (Peng & Kim, 1994), it 
appears that acid-denatured HSA at pH 2.0 represents the molten globule state of 
the protein. 
(v) Intrinsic fluorescence: Figure 14 shows the effect of pH in the 6.5-2.0 range 
on tryptophan fluorescence maximum, X-max- The tryptophan fluorescence 
emission spectra for HSA in the native state at pH 6.0 and acid-denatured state at 
pH 2.0 in the 300-400 nm range after exciting the protein at 280 nm are shown in 
Figure 15. The native state of HSA was characterized by the emission maximum 
at 340 nm. Lowering the pH to 2.0 caused a blue shift of 12 nm (Table 3) and 
increase in fluorescence intensity, indicating internalization of tryptophan in a 
non-polar environment which was otherwise located between the IIA and IIIA 
interface in the native state (He & Carter, 1992) near the surface of the protein 
molecule, as judged by its sensitivity to photo-oxidation (Reddi et al, 1987). 
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Figure 14. pH-dependence of emission maxima, X,,^  of intrinsic 
fluorescence of HSA. 
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Figure 15. Fluorescence spectra of native HSA at pH 6.0 (curve 1) 
and acid-denatured HSA at pH 2.0 (curve 2). 
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(vi) Acrylamide quenching: To confirm the environment of the tryptophan 
residue, we compared the exposure of the single tryptophan residue, Trp214, in 
the native state with that in the acid-denatured state and GdnHCl-denatured state 
by a fluorescence-quenching experiment, using uncharged molecules of 
acrylamide as described by Eftink & Ghiron (1982). Stem-Volmer plots of 
quenching of fluorescence by acrylamide in native, acid-denatured and GdnHCl-
denatured HSA are depicted in Figure 16. Results for the tryptophan analogue 
NATA are also included as a standard for complete accessibility to quencher. 
Table 4 shows the Stem-Volmer constants (Ksv) fitted to the early linear parts of 
the curves in Figure 16. Ksv for the native state was found to be higher (5.9) than 
that for the acid-denatured state (4.0) and was accompanied by a blue shift in 
m^ax from 342 to 334 nm. These results indicate that the tryptophan residue in the 
native state was more accessible to quenching by acrylamide than in the acid-
denatured state. The blue shift in the emission maximum of tr3^tophan indicated 
that the residue became more inaccessible to the solvent in the acid-denatured 
state. That the Ksv values for the GdnHCl-denatured state and NATA were 
significantly higher than those for the native and acid-denatured states suggests 
that, even in the native state, the tryptophan residue was not fiilly accessible, 
which is in agreement with previous results (Peterman & Laidler, 1980). 
(vii) Intrinsic viscosity: Intrinsic viscosity measurements were performed to 
detect conformational changes in native HSA. The intrinsic viscosity values, [TI]. 
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Figure 16. Stem-volmer plots of acrylamide quenching. Native 
HSA at pH 6.0 (•); acid-denatured HSA at pH 2.0 (o); GdnHCl-
denatured HSA (A) and NATA (A). Values shown are the ratios of 
fluorescence in the absence of acrylamide (Fo) to the fluorescence 
at that concentration of quencher (F). 
67 
Table 4 
Acrylamide-quenching parameters of different states of HSA 
Subjec t Ksv (M-^) ?lniax' 
Native HSA 5.9 342 
Acid-denatured HSA 4.0 334 
GdnHCl-denatured HSA 9.7 350 
NATA 20.7 354 
^ Excitation wavelength was 295 nm. 
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as calculated from the intercept on the Y-axis of the rjred versus protein 
concentration plot, for the native and acid-denatured HSAs are listed in Table 3 
(Figures 17 and 18). Value of [rj] for GdnHCl-denatured state of HSA was taken 
from Tanford (1967) and is also listed in Table 3. The value measured for the 
acid-denatured state (8.4 cc/g) was a little more than twice that measured for the 
native state (3.9 cc/g), but was considerably lower than that of the GdnHCl-
denatured state (22.9 cc/g). In the light of the molten globule theory, these data 
indicate that the compactness of HSA at acidic pH was similar to the molten 
globule state of other proteins (Bychkova et al., 1992). 
Taken together, these results, i.e. the presence of a high content of 
secondary structure (~42% a-helix), higher magnitude of ANS binding, loss of 
cooperativity in the thermal transition and significant loss of tertiary structure but 
retention of compactness, suggest that the acid-denatured state of HSA at pH 2.0 
resembles the molten globule state as defined for other proteins. However, it 
should be remembered that HSA contains three domains which are assumed to 
fold independently (Khan, 1986). In view of previous results showing uncoiling 
of domain III on acidification, loss of secondary structure may be attributed to 
unfolding of domain III, whereas retention of other properties similar to those of 
the native state can be ascribed to domains I and II. 
3. Alcohol-induced partially folded states atlowpH 
Figure 19 shows the far-UV CD spectra in the 200-250 nm range of native 
HSA at pH 7.0 (curve 2), the acid-denatured HSA at pH 2.0 (curve 1) and the 
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Figure 17. Reduced viscosity of HSA as a function of protein 
concentration at pH 7.0, 25°C. 
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Figure 18. Reduced viscosity of HSA as a function of protein 
concentration at pH 2.0, 25''C. 
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Figure 19. Far-UV CD spectra of different states of HSA. Native 
state at pH 7.0 (curve 2); acid-denatured state at pH 2.0 (curve 1) 
and aicohol-induced state at pH 2.0 in presence of 8.4 M TFE 
(curve 3). 
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acid-denatured HSA in the presence of 8.4 M TFE (curve 3). All these spectra 
were characterized by the presence of two minima, one at 208 nm and the other 
at 222 nm, characteristic of a-heUcal structure. Though a significant amount 
(42%) of a-helical structure was retained in the acid-denatured HSA compared to 
native HSA containing 58% a-helix, around 24% decrease in the MRE222 value 
was observed in acid-denatured HSA, Presence of 8.4 M TFE in the acid-
denatured HSA solution showed a remarkable increase (67%) in MRE222 value 
which was 26% higher than the MRE222 value of native HSA. Calculation of the 
a-helical content from MRE222 value showed the presence of 75% a-helical 
structure in the presence of 8.4 M TFE. This was in agreement with earlier 
reports suggesting the helix-induction potential of TFE (Schonbrunner et ai, 
1996; Luo & Baldwin, 1997). 
In view of the remarkable increase in MRE222 value observed in the 
presence of 8.4 M TFE, we studied the effect of different concentrations of TFE 
on the far-UV CD spectra of acid-denatured HSA and the dependence of MRE222 
on TFE concentration is shown in Figure 20. As can be seen from the figure, 
addition of TFE to acid-denatured HSA (curve 1) led to an increase in the helical 
content as evident from the increase in MRE222 value (curves 2-8) which became 
almost similar to that found for native HSA, at 0.7 M TFE. Further increase in 
the TFE concentration (>0.7 M) induced more helical structure reaching to a 
saturation around 8.4 M TFE (curve 8). The CD spectra at different 
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Figure 20. Far-UV CD spectra of acid-denatured HSA as a 
function of TFE concentration in 10 mM glycine-HCl buffer, 
pH 2.0 and at 25*'C. The concentrations of TFE for different 
spectra from the top were: 0 M, 0.7 M, 1.4 M, 2.1 M, 2.8 M, 4.2 
M, 5.6 M and 8.4 M upto curve 8. The protein concentration was 
4.7 nM and the pathlength was 0.1 cm. 
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concentrations of TFE showed an isodichroic point at 202 nm, which was 
consistent with a two-state approximation (acid-denatured and a-helical states). 
Eariier studies have suggested differences in heUx-stabiUzing potential of 
different alcohols (Hirota et al., 1997; Konno et al., 2000). Therefore, we studied 
the effect of various alcohols on the acid-denatured state of HSA by MRE222 
measurements. Transition curves induced by different alcohols, i.e. methanol, 
ethanol, isopropanol, tert-butanol, 2-chloroethanol, TFE and HFIP are shown in 
Figure 21. All alcohols were found to induce helicity in the acid-denatured HSA. 
However, quantitative differences were noted in the transition curves both in 
terms of maximum ellipticities and concentration range required to bring about 
the transition (see Figure 21). The ellipticity (MRE222) values obtained at the 
maximum concentration of alcohols are shown in Table 5. A comparison of these 
values observed with different alcohols (Table 5) suggested that the helical 
content induced in the protein was independent of alcohol species. Alcohol-
induced conformational transitions of acid-denatured HSA were approximated 
using a two-state model as CD spectra of acid-denatured HSA at different TFE 
concentrations showed an isodichroic point at 202 nm (Figure 20). Dependence 
of the free energy change (AGH) of the transition to the helical state on alcohol 
concentration is shown in Figure 22. AGH decreased linearly with an increase in 
alcohol concentration in all cases. Further, the same value of AGH (H2O) was 
observed with all alcohols, showing independence of AGH (H2O) on alcohol 
species. Values of 'm' calculated from the linear curves using least squares 
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Figure 21. Alcohol-induced conformational transitions of HSA 
studied in 10 mM glycine-HCl buffer, pH 2.0 by measuring MRE 
at 222 nm. Different alcohols used were, methanol (o), ethanol 
(•), isopropanol (•), tert-butanol (A), 2-chloroethanol ( v ) , TFE 
(•)andHFIP(o) . 
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Table 5 
Characteristics of alcoliol-induced transition of acid-denatured HSA as 
studied by far-UV CD 
Alcohol 
Methanol 
Ethanol 
Isopropanol 
tert-Butanol 
2-Chloroethanol 
TFE 
HFIP 
C ^ 
(M) 
7.45 
4.34 
2.67 
1.56 
1.25 
0.84 
0.20 
(deg 
MRE222*' 
i.cm .^dmol"') 
22 500 
23 500 
24 200 
24 800 
24 800 
25 200 
25 500 
m' 
(cal/mol/M) 
108 
194 
348 
538 
746 
1022 
4977 
* Calculated from Figure 22. 
Obtained from Fig:ure 21 at the maximum concentration of alcohol. 
'^ Calculated from Figure 22. 
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Figure 22. Dependence of AGH of HSA on alcohol concentration. 
Methanol (o), ethanol (•), isopropanol (•), tert-butanol (A), 2-
chloroethanol (v) , TFE ( • ) and HFIP (O). AGH values were 
obtained from the transition curves shown in Figure 21. Common 
baseline ellipticity values for acid-denatured and (X-helical states 
of HSA were -15100 and -24500, respectively. 
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analysis are given in Table 5. Values of Cm calculated from these curves are also 
shown in column 1 of Table 5. A comparison of Cm and m values obtained with 
different alcohols suggests that HFIP was most effective in inducing a-helical 
structure among all the alcohols used. Contrary to this, methanol and ethanol 
were least effective in inducing a-helical structure and thus required much higher 
concentration. The order of effectiveness of various alcohols was found to follow 
the series: 
HFIP>TFE>2-chloroethanol>tert-butanol>isopropanol>ethanol>methanol 
A similar pattern of effectiveness of various alcohols on the unfolded state 
of melittin has been reported by Hirota et al. (1997). Higher helix-induction 
potential of HFIP and TFE can be ascribed to the presence of bulky alkyl groups 
and greater F atoms. 
To probe the asymmetry of protein's aromatic amino acids' environment, 
near-UV CD spectra in the 250-300 nm range of native and acid-denatured HSA, 
both in the absence and presence of 8.4 M TFE were studied and the results are 
shown in Figure 23. The spectra for the native HSA was characterized by the 
presence of two minima at 262 nm and 268 nm (curve 1), characteristic of 
disulfides and aromatic chromophores (Lee & Hirose, 1992). Acid-denatured 
HSA also produced qualitatively similar near-UV CD spectra retaining both the 
features. However, a marked decrease in MRE values was noted (curve 2), 
showing a decrease in the asymmetry of protein's tertiary structure. Presence of 
8.4 M TFE in acid-denatured HSA solution further reduced the MRE value at 
-230 
Wavelength (nm) 300 
Figure 23. Near-UV CD spectra of diflferent states of HSA. 
Native state at pH 7.0 (curve 1); acid-denatured state at pH 2.0 
(curve 2) and alcohol-induced state at pH 2.0 in presence of 8.4 M 
TFE (curve 3). The protein concentration was 26 \xM in a 1 cm 
pathlength cell. 
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262 nm (curve 3), showing denaturation effect of the alcohol. These results were 
in line of an earlier report which suggested the disruption of tertiary structure of 
protein in presence of alcohol (Kamatari et al, 1996). 
Effect of tert-butanol on the tertiary structure of acid-denatured HSA was 
also studied using tryptophan fluorescence emission spectra for native and acid-
denatured HSA, both in the absence and presence of 6.2 M tert-butanol (Figure 
24). The emission spectra of native HSA was characterized by the emission 
maxima at 340 nm (curve 1). Acid denaturation of HSA caused a blue shift of 10 
nm and an increase in fluorescence intensity (curve 2) indicating internalization 
of tryptophan in more apolar environment from the interface of subdomains IIA 
and IIIA in the native state (He & Carter, 1992). Presence of 6.2 M tert-butanol 
fiirther placed the tryptophan more deeper in apolar environment as judged by the 
marked increase in fluorescence intensity and significant blue shift fi-om the acid-
denatured state (curve 3). This seems to be understandable as more helical 
structure was induced in presence of alcohols. Halogenated alcohols showed 
different effects compared to alkanols as little or no increase in fluorescence was 
noticed upon their addition to acid-denatured HSA (data not shown). 
A marked enhancement in fluorescence intensity of acid-denatured HSA 
in the presence of tert-butanol prompted us to study the dependence of 
tryptophan fluorescence on alcohol concentration. Figure 25 shows various 
transition curves obtained in the presence of different alcohols as monitored by 
tryptophan fluorescence measurement at 330 nm. Among all the alcohols studied, 
halogenated alcohols showed anomalous behavior as increase in alcohol 
300 400 
Wavelength (nm) 
Figure 24, Tryptophan fluorescence emission spectra of HSA m 
the native state in 60 mM sodium phosphate buffer, pH 7.0 (curve 
1), acid-denatured state iu 10 mM glycine-HCl buffer, pH 2.0 
(curve 2) and acid-denatured state in 10 mM glycine-HCl buffer, 
pH 2.0 containing 6.2 M tert-butanol (curve 3). The protein 
concentration was 1.8 fiM in a 1 cm padilengtfa cell. 
8 12 
Alcohol (M) 
16 
Figure 25. Alcohol-induced conformational transitions of acid-
denatured HSA studied in 10 mM glycine-HCl buffer, pH 2.0 by 
measuring tryptophan fluorescence at 330 nm. Different alcohols 
used were; methanol (o), ethanol (•), isopropanol (•), tert-butanol 
(A), 2-chloroethaiiol (v), TFE ( • ) and HFIP (o). 
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concentration led to an initial decrease followed by a continuous increase in 
fluorescence. Decrease in tryptophan fluorescence of acid-denatured HSA at 
lower alcohol concentrations reflects a compact denatured state. Such kind of 
decrease has also been shown in an earlier study on cytochrome c in the presence 
of HFIP (Konno et al., 2000). Contrary to this, remaining alcohols (alkanols) 
such as methanol, ethanol, isopropanol and tert-butanol showed the normal 
transition curves in which increase in alcohol concentration led to an increase in 
fluorescence intensity in a cooperative manner. Among these alcohols, the order 
of effectiveness was found to be: 
tert-butanol > isopropanol > ethanol > methanol 
This shows that the helix stabilizing potential of these alcohols is directly 
correlated with the bulkiness of alkyl group as tert-butanol was found to be most 
effective. 
ANS fluorescence has been used as a probe to monitor the conformational 
transitions in proteins due to its affinity towards the hydrophobic regions of 
proteins (Kuwajima, 1989; Engelhard & Evans, 1995). Figure 26 shows the ANS 
fluorescence emission spectra of native HSA, acid-denatured HSA both in the 
absence and presence of TFE. Acid-denatured HSA has been found to have more 
ANS binding sites (curve 2) than native HSA (curve 1) as indicated by the 
increase in ANS fluorescence in acid-denatured HSA. Presence of 8.4 M TFE in 
HSA solution at pH 2.0 resulted in a remarkable decrease in fluorescence (curve 
3) which was even lower than the fluorescence of native HSA (curve 1). Further, 
a red shift of 30 nm was also noted. This decrease in ANS fluorescence was 
400 600 
Wavelength (nm) 
Figure 26. Fluorescence emission spectra of ANS bound to 
native HSA at pH 7.0 (curve 1); acid-denatured state at pH 2.0 
(curve 2) and alcohol-induced state at pH 2.0 in presence of 8.4 M 
TFE (curve 3). The excitation wavelength was 380 nm. 
85 
indicative of the close packing of hydrophobic residues of the protein which was 
even higher than the packing of these residues in native HSA. This is because at 
higher TFE concentration, the fluorescence emission spectra approached that of 
free ANS solution (data not shown) indicating the non-availability of 
hydrophobic regions of protein due to their internalization. 
Dependence of ANS fluorescence on TFE concentration led us to use this 
probe to monitor the conformational transition of acid-denatured HSA to alcohol-
induced state. Figure 27 shows the change in relative fluorescence at 480 nm 
against alcohol concentration. As can be seen from the figure, increase in alcohol 
concentration led to a decrease in ANS fluorescence showing the non-availability 
of hydrophobic regions for binding in the presence of alcohols. Such kind of 
decrease in ANS fluorescence has also been observed earlier (Alexandrescu et 
al., 1994). Data shown in Figure 27 indicated different conformational states of 
the protein induced by different alcohols as well as their effectiveness in inducing 
a particular state. A comparison of the data shown in Figure 27 with those of 
Figure 21 suggests that the conformational states induced by HFIP and tert-
butanol which were indistinguishable in terms of helical content, showed 
differences in the ANS binding sites being higher in tert-butanol-induced state 
than HFIP-induced state. A comparison of the Cm values obtained from Figure 27 
(Table 6) shows HFIP to be most effective among all the alcohols used. These 
values were similar to those obtained from Figure 21. The order of effectiveness 
of various alcohols was found to be: 
HFIP>TFE>2-chloroethanol>tert-butanol>isopropanol>ethanol>methanol 
0 4 6 8 
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Figure 27. Alcohol-induced conformational transitions of HSA 
studied in 10 mM glycine-HCl buffer, pH 2.0 by measuring ANS 
fluorescence at 480 nm. Different alcohols used were: methanol 
(o), ethanol (•), isopropanol (•), tert-butanol (A), 2-chloroethanol 
(v), TFE (T) and HFIP (o). 
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Table 6 
Characteristics of alcohol-induced transition of acid-denatured 
HSA studied by ANS fluorescence 
Alcohol C 
' Calculated from Figure 27. 
a 
m (deg.cm .dmol") 
Methanol 6.59 
Ethanol 3.93 
Isopropanol 3.38 
tert-Butanol 2.27 
2-Chloroethanol 1.40 
TFE 1.00 
HFIP 0.50 
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This order was exactly similar to the one observed with MRE measurements. 
From these results it can be said that the addition of alcohol to the acid-denatured 
HSA induces a state characterized by more helical structure and highly 
internalized hydrophobic regions. Cooperative transition from the acid-denatured 
state to alcohol-induced state observed with different alcohols suggested the 
relative effectiveness of various alcohols in inducing the transition. Although it 
is widely accepted that alcohols induce the secondary structure in proteins 
(Herskovits et al., 1970; Lehrman et ai, 1990; Shiraki et al., 1995; Konno et al, 
2000), the mechanism of these effects is still not clearly understood. In a 
previous study, comparative effect of alcohols has been explained on the basis of 
additive function of methyl groups (Hirota et al., 1997). However, strong 
effectiveness of fluorinated alcohols has been suggested to involve some 
additional factors. In view of the micelle-like assembly of water miscible 
alcohols in aqueous solution (Franks & Desnoyers, 1986; Mizutani et al, 1991; 
Kuprin et al., 1995; Koga, 1996), it appears that these alcohols interact with acid 
denatured HSA (having several hydrophobic residues exposed) through their 
hydrophobic regions, thus decreasing the environmental polarity around the 
polypeptide which in turn favors the formation of hydrogen bonds resulting in 
helical structure. Further, stronger X-ray scattering by HFIP-water mixture as 
compared to other alcohol-water mixtures indicating the stronger formation of 
HFIP clusters (Kuprin et al, 1995) accounts for the higher potential of HFIP in 
inducing helical structure in acid-denatured HSA. 
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4. Urea-induced transition ofHSA 
Figures 28 and 29 show the urea-induced equilibrium unfolding of HSA 
as studied by MRE and intrinsic fluorescence measurements at 222 and 340 nm, 
respectively. Urea-induced unfolding of HSA showed a two-step transition from 
native (N) state to denatured (D) state with a stable intermediate (I) state around 
4.6-5.2 M urea. The first transition, showing the transformation of N state to the I 
state, started around 2 M urea and completed at 4.5 M urea with a mid point at 
3.9 M urea. The second transition, (I—D) started at 5.2 M urea and finally 
sloped off at ~8.8 M urea with a mid point at -6.6 M urea concentration. Similar 
values were obtained when the transition was studied by intrinsic fluorescence 
measurements. 
The equilibrium denaturation of HSA by urea was found to be completely 
reversible and changes in the fluorescence and CD signal may be described by a 
three-state, two-step denaturation/renaturation model with a stable intermediate 
populated around 4.6-5.2 M urea. These results were in accordance with the 
earlier results reported for HSA and BSA (Muzammil et ai, 2000; Khan et al, 
1987; Ahmad & Qasim, 1995). This intermediate retained a significant amount of 
secondary structure (37%) compared to 58% found in native protein. 
5. Effect of alcohols on the urea-induced transition of HSA 
(i) Effect of TFE: Effect of TFE on the conformational stability of HSA was 
examined by studying urea-induced denaturation of HSA in the presence of 
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Figure 28. Urea-induced unfolding (open circles) and refolding 
(filled circles) of HSA in 0.06 M sodium phosphate buffer, pH 
7.0, 25°C. The unfolding/refolding were followed by measuring 
MRE at 222 nm. 
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Figure 29. Urea-induced unfolding (open hexagons) and refolding 
(filled hexagons) of HSA in 0.06 M sodium phosphate buffer, pH 
7.0, 25"C. The unfolding / refolding were followed by measuring 
fluorescence at 340 nm upon excitation at 280 nm. 
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different concentrations of TFE. Figure 30 shows the urea-induced transition of 
HSA at pH 7.0, 25°C as followed by MRE measurements at 222 nm in the 
absence (curve 1) and presence of increasing concentrations of TFE (curves 2-5). 
The transition curves (curves 2-5) obtained in the presence of different 
concentrations of TFE were found to be single-step (N—D) without any 
intermediate state against a two-step transition curve (curve 1) obtained for HSA 
in the absence of TFE. The denaturation curve of HSA in the presence of 
increasing concentrations (0.5-3.0 M) of TFE was shifted towards higher urea 
concentration, as the mid point of transition observed in the presence of 3 M TFE 
was 6.7 M urea against 5.6 M noted in the presence of 0.5 M TFE. 
Urea denaturation curves of HSA (in the absence as well as presence of 
3M TFE) were normalized assuming a two-step transition for the former and a 
single-step transition for the later as described in Experimental section. The 
normalized curves, thus obtained, are shown in Figures 31 and 32. Assuming 
both the transitions shown in Figure 31 (N= I^ and I=f^ D transitions) to follow a 
two-state mechanism, I calculated the free energy of unfolding, AGi and AGD, 
respectively, as a fimction of urea concentration as described in equations (11) 
and (13). Similarly, for the transition curve (Figure 32) in the presence of 3 M 
TFE, values of AGD were calculated using equation (7). Figures 33 and 34 show 
the variation of AG as a fiinction of urea concentration. A least squares analysis 
H O HO 
was used to fit the data to equation (14) to calculate AGj 2 , AGD* and AGD ^ (in 
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Figure 30. Urea-induced unfolding of HSA as followed by MRE 
measurements at 222 nm at pH 7.0, 25°C in the absence (curve 1) 
and presence of different concentrations of TFE viz. 0.5 M TFE 
(curve 2); 1.0 M TFE (curve 3); 2.0 M TFE (curve 4) and 3.0 M 
TFE (curve 5). 
3 
4J 
Xi 
s o 
2 
1.0 
0.8 
0.6 
0.4 
0.2 
0.0 C 
— 
— 
I 
N^i y 
i 1 1 1 1 
f l^D 
1 1 t i 
0 4 6 
Urea (M) 
8 10 
Figure 31. Normalized curves for the transitions (N^I and I^ ^^ D) 
of urea-induced unfolding of HSA as followed by measuring 
MRE at 222 nm. 
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Figure 32. Normalized curve for the transition (N=?^ D) of urea-
induced unfolding of HSA in the presence of 3.0 M TFE. 
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Figure 33. Dependence of free energy change on urea 
concentration for the transitions shown in Figure 31. 
o 
I 
O 
< 
1800 
1200 -
600 -
0 
-600 -
-1200 -
1800 
6 7 
Urea (M) 
8 
Figure 34. Dependence of free energy change on urea 
concentration for the transition shown in Figure 32. 
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the presence of TFE). Value of AGD* represents the value obtained from the 
extrapolation of AGD values up to the start of the process, I—D. Table 7 
HO HO 
summarizes the AG 2 values under different conditions. The AGi 2 and m values 
obtained for the first transition (N^I) were 3,510 cal/mol and 910 cal.mor'.M"' 
of urea concentration, respectively, whereas AGD » the free energy change 
associated with I=^D transition was found to be 1850 cal/mol and m value as 810 
cal.mor'.M''. Free energy change associated with N^D transition in the absence 
of TFE can be obtained by summing the free energy change of the individual 
steps, i.e. AGi 2 and AGD • Therefore, AG 2 ^^^^^ i.e., the free energy change 
associated with the transformation from N state to I state and finally to D state, 
HO 
was calculated to be 5360 cal/mol. The AGD ^ and m values for N^D transition 
in the presence of 3M TFE were calculated to be 8040 cal/mol and 1190 cal. 
H O 
mor'.M"', respectively. The free energy of stabilization AAGD 2, i.e., the free 
energy change of unfolding of HSA in the presence of TFE than in its absence 
was found to be 2680 cal/mol. 
Similar stabilizing effect of TFE was also noticed when the urea-induced 
transition of HSA was monitored by fluorescence measurements (Figures 35-38). 
Data were treated in the same way as described above (see Table 7). Values of 
H O * 
AGI ^ and AGD for the first and second transitions were determined to be 3490 
cal/mol and 1850 cal/mol, respectively whereas the m values for the two 
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Table 7 
Values of conformational free energy of HSA obtained from analysis of CD 
and fluorescence data. 
H.O . „ . _ H O . „ H.O* 
AG, 2 AG,,* AGtotai 2 AG,, 2 
H O (N^I) (I^D) ( N ^ I ^ D ) (N^D) AAG,, 2 
Probe (cal/mol) (cal/mol) (cal/mol) (cal/mol) (cal/mol) 
MRE222 3,510 1,850 5,360 8,040 2,680 
Fluorescence''3,490 1,850 5,340 8,060 2,720 
^Determined in the presence of 3M TFE. 
''Excitation and emission wavelengths were 280 and 340 nm, respectively. 
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Figure 35. Normalized curves for the transitions (N=?^ I and I^D) 
of urea-induced unfolding of HSA as followed by measuring 
intrinsic fluorescence at 340 nm after excitation at 280 nm. 
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Figure 36. Normalized curve for the transition (N=f^ D) of urea-
induced unfolding of HSA in the presence of 3.0 M TFE as 
followed by measuring intrinsic fluorescence at 340 nm after 
excitation at 280 nm. 
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Figure 37. Dependence of free energy change on urea 
concentration for the transitions shown in Figure 35. 
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Figure 38. Dependence of free energy change on urea 
concentration for the transitions shown in Figure 36. 
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H O 
transitions were 900 and 805 calmol''. M"', respectively. AG 2 total was calculated 
to be 5340 cal/mol. The free energy change, AGD^ for the transition (N—D) in 
the presence of 3M TFE was calculated to be 8060 cal/mol and m value as 1200 
cal.mol'.M"'. Therefore, AAGQ^ as obtained by fluorescence measurements was 
found to be 2720 cal/mol. These results were in close agreement with those 
obtained by MRE measurements. The urea-induced transition of HSA in the 
presence of TFE followed a two-state mechanism without any detectable 
intermediate. Earlier studies have also shown an increase in the structural 
stability of many globular proteins in the presence of low concentrations of 
organic solvents (Jirgensons, 1967; Ohama et al., 1977; Asakura et al., 1978). In 
view of the primary involvement of domain III in the intermediate formation 
(Muzammil et al., 2000; Ahmad & Qasim, 1995; Tayyab et al, 2000), it appears 
that TFE mainly stabilizes domain III against urea denaturation. 
Figure 39 shows the normalized transition curves of urea denaturation of 
HSA both in the absence as well as presence of 3M TFE, obtained by plotting FD 
against urea concentration, when studied by ANS binding. Both transition curves 
showed a single-step transition. However, the mid point of transition was shifted 
towards higher urea concentration (6.7 M) in the presence of 3 M TFE against 
5.5 M in its absence. A hydrophobic environment may stabilize or even induce 
native-like structure in a peptide chain as evident by the maintenance of many 
native-like characteristics by lysozyme, ubiquitin and peptide fragment of a-
lactalbumin in TFE-containing solution (Buck et al, 1993; Stockman et al. 
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Figure 39. Normalized transition curves for urea-induced 
unfolding of HSA as monitored by ANS fluorescence 
measurements at pH 7.0, 25°C in the absence (open circle) and 
presence of 3 M TFE (filled circle). Concentrations of protein and 
ANS were 1.8 pM and 90 |JM, respectively. 
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1993; Alexandrescu et al., 1993). Though, alcohols at higher concentrations have 
been reported to denature proteins by weakening the hydrophobic interactions, 
but stabilize the peptide helices in proteins (Hermans, 1966). Many organic 
solvents at low concentrations increase the structure of solvent water and thus 
enhance hydrophobic interactions (Goldammer & Hertz, 1970; Ben-Naim, 1980), 
which may be responsible for the stabilization of native protein structure. 
Further, reduced dielectric constant of TFE (as compared to that of pure water) 
favoring intramolecular hydrogen bonding and electrostatic interactions may also 
add towards the stabilization of folded state in TFE. 
(ii) Effect of different alcohols: In view of the stabilizing effect of TFE, 
stabilizing potential of other alcohols was analyzed by studying the refolding 
behavior of HSA at 5 M urea, where intermediate (I) state exists, both by MRE 
and intrinsic fluorescence measurements at 222 imi and 340 nm, respectively. 
Figure 40 shows the dependence of MRE222 value at 5 M urea in the absence and 
presence of different alcohols (TFE, HFIP, 2-chloroethanol, tert-butanol, 
isopropanol, ethanol and methanol) on molar alcohol concentration. The extent of 
refolding induced by all the alcohols was found to be similar at higher alcohol 
concentrations. On the other hand, at lower alcohol concentrations (<1.0 M), the 
extent of refolding was found to be different for different alcohols. Cm values as 
determined from Figure 40 for different alcohols are given in Table 8. As can be 
seen from Figure 40 and Table 8, the relative effectiveness of various alcohols in 
refolding of HSA followed the series: 
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Figure 40. Effect of various alcohols on the refolding of HSA at 
5.0 M urea and at pH 7.0, 25°C as studied by MRE222 
measurements. Different alcohols used were: HFIP (o); TFE (A); 
2-chloroethanoI (A); tert-butanol (•); isopropanol (n); ethanol (•) 
and methanol (o). The protein concentration was 3 p,M. 
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Table 8 
Alcohol-induced refolding of HSA 
Alcohol 
MRE222 
4.90 
2.40 
2.20 
1.40 
0.96 
0.46 
0.16 
Cm value (M)' 
Fluorescence 
•4.90 
3.90 
3.00 
2.45 
2.02 
0.92 
0.40 
Methanol 
Ethanol 
Isopropanol 
tert-Butanol 
2-Chloroethanol 
TFE 
HFIP 
^Calculated from the data of Figures 40 and 41. 
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HFIP>TFE>2-chloroethanol>tert-butanol>isopropanol>ethanol>methanol 
Similar effect of these alcohols was also noticed when studied by intrinsic 
fluorescence measurements (see Figure 41 and Table 8). Alcohols used in this 
study were found to promote refolding of the intermediate state which may be 
ascribed to the complex folding mechanism of serum albumin involving 
independent folding of domains and their subsequent interactions to give rise a 
native structure 
6. GdnHCl-induced transition ofHSA 
The unfolding of HSA was also performed using GdnHCl as a denaturant. 
The transition was found to follow a single-step, two-state transition as 
monitored by measuring MRE at 222 nm. Figure 42 shows the normalized 
transition curves of HSA as obtained in the absence as well as presence of 3 M 
TFE as a function of GdnHCl concentration. The free energy of unfolding, 
H O 
AGD 2 and m values were calculated to be 5,860 cal/mol and 2,020 cal.mol'.M'^ 
respectively in the absence of TFE whereas with TFE, these values were found to 
be 8,245 cal/mol and 2100 cal.mol'.M"^ (Figure 43). A comparison of these 
H O 
values gave the AAGD ^ value in the presence of TFE as 2385 cal/mol, which 
was similar to the value obtained in urea transition of HSA. 
GdnHCl is considered to be a much stronger denaturant than urea (Pace, 
1990) although the relative effectiveness of two denaturants depends on the 
nature of protein (Greene & Pace, 1974). Both urea and GdnHCl are presumed to 
bind to peptide bonds (Robinson & Jencks, 1965; Roseman & Jencks, 1975). 
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Figure 41. Effect of various alcohols on the refolding of HSA at 
5.0 M urea and at pH 7.0, 25°C as studied by intrinsic 
fluorescence measurements. Different alcohols used were: HFIP 
(open triangle); TFE (filled triangle); 2-chloroethanol (open 
hexagon); tert-butanol (filled square); isopropanol (open square); 
ethanol (filled circle) and methanol (open circle). The protein 
concentration was 1.8 x^M. 
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Figure 42. Normalized transition curves for GdnHCl-induced 
unfolding of HSA in the absence (filled circle) and presence (open 
circle) of 3 M TFE as monitored by MRE measurements at 222 
nm at pH 7.0, 25''C. 
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Figure 43. Dependence of free energy change on GdnHCI 
concentration for the transitions shown in Figure 42. 
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Since there are a greater number of non-interacting binding sites on the unfolded 
conformation than folded conformation, the protein unfolds and more sites are 
exposed to the denaturant molecules (Mayo & Baldwin, 1993; Monera et al., 
1994). GdnHCl-induced denaturation of HSA was also stabilized in the presence 
of TFE as transition was shifted to higher GdnHCl concentration in the presence 
of TFE. Thus, it appears that TFE competes for those sites where GdnHCl binds 
thereby protects the structure from undergoing denaturation. 
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